CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | O-methyleugenol |
|
Accession: | CHEBI:4918
|
browse the term
|
Definition: | A phenylpropanoid that has formula C11H14O2. |
Synonyms: | exact_synonym: | 1,2-dimethoxy-4-(prop-2-en-1-yl)benzene |
| related_synonym: | 1,2-Dimethoxy-4-(2-propenyl)benzene; Eugenol methyl ether; Formula=C11H14O2; InChI=1S/C11H14O2/c1-4-5-9-6-7-10(12-2)11(8-9)13-3/h4,6-8H,1,5H2,2-3H3; InChIKey=ZYEMGPIYFIJGTP-UHFFFAOYSA-N; Methyl eugenol; Methyleugenol; SMILES=COc1ccc(CC=C)cc1OC |
| xref: | BPDB:2504; CAS:93-15-2; KEGG:C10454; KNApSAcK:C00002741 |
| xref_mesh: | MESH:C005223 |
|
|
|
G |
AASS |
aminoadipate-semialdehyde synthase |
decreases expression |
EXP |
methyleugenol results in decreased expression of AASS mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:122,073,549...122,144,249
Ensembl chr 7:122,064,583...122,144,308
|
|
G |
ABAT |
4-aminobutyrate aminotransferase |
decreases expression |
EXP |
methyleugenol results in decreased expression of ABAT mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:8,674,617...8,784,570
Ensembl chr16:8,674,596...8,784,575
|
|
G |
ABCA1 |
ATP binding cassette subfamily A member 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ABCA1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
|
|
G |
ABCA6 |
ATP binding cassette subfamily A member 6 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ABCA6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:69,078,702...69,141,895
Ensembl chr17:69,078,702...69,141,895
|
|
G |
ABCB11 |
ATP binding cassette subfamily B member 11 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ABCB11 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
|
|
G |
ABCB4 |
ATP binding cassette subfamily B member 4 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ABCB4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:87,365,896...87,476,027
Ensembl chr 7:87,401,696...87,480,435
|
|
G |
ABCC11 |
ATP binding cassette subfamily C member 11 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ABCC11 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:48,164,819...48,247,539
Ensembl chr16:48,165,773...48,247,568
|
|
G |
ABCC6 |
ATP binding cassette subfamily C member 6 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ABCC6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:16,149,565...16,223,494
Ensembl chr16:16,149,565...16,223,522
|
|
G |
ABCC6P1 |
ATP binding cassette subfamily C member 6 pseudogene 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ABCC6P1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:18,571,248...18,598,289
Ensembl chr16:18,571,276...18,592,716 Ensembl chr16:18,571,276...18,592,716
|
|
G |
ABCC9 |
ATP binding cassette subfamily C member 9 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ABCC9 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:21,797,389...21,941,426
Ensembl chr12:21,797,389...21,942,543
|
|
G |
ABCG5 |
ATP binding cassette subfamily G member 5 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ABCG5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:43,806,211...43,839,231
Ensembl chr 2:43,812,472...43,838,865
|
|
G |
ABCG8 |
ATP binding cassette subfamily G member 8 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ABCG8 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:43,838,971...43,882,988
Ensembl chr 2:43,831,942...43,882,988
|
|
G |
ABHD2 |
abhydrolase domain containing 2, acylglycerol lipase |
decreases expression |
EXP |
methyleugenol results in decreased expression of ABHD2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:89,040,998...89,202,355
Ensembl chr15:89,087,459...89,202,355
|
|
G |
ACAA1 |
acetyl-CoA acyltransferase 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ACAA1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:38,122,715...38,137,127
Ensembl chr 3:38,103,129...38,137,242
|
|
G |
ACACB |
acetyl-CoA carboxylase beta |
decreases expression |
EXP |
methyleugenol results in decreased expression of ACACB mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:109,111,189...109,268,226
Ensembl chr12:109,116,587...109,268,226
|
|
G |
ACAT2 |
acetyl-CoA acetyltransferase 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ACAT2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:159,762,045...159,779,112
Ensembl chr 6:159,762,045...159,779,112
|
|
G |
ACHE |
acetylcholinesterase (Yt blood group) |
increases expression |
EXP |
methyleugenol results in increased expression of ACHE mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
|
|
G |
ACMSD |
aminocarboxymuconate semialdehyde decarboxylase |
decreases expression |
EXP |
methyleugenol results in decreased expression of ACMSD mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:134,838,616...134,902,034
Ensembl chr 2:134,838,616...134,902,034
|
|
G |
ACNATP |
acyl-CoA:amino acid N-acyltransferase, pseudogene |
decreases expression |
EXP |
methyleugenol results in decreased expression of ACNATP mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:101,334,092...101,339,347
Ensembl chr 9:101,334,084...101,339,347
|
|
G |
ACOT1 |
acyl-CoA thioesterase 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ACOT1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:73,490,933...73,543,796
Ensembl chr14:73,537,143...73,543,796
|
|
G |
ACOT11 |
acyl-CoA thioesterase 11 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ACOT11 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:54,548,228...54,639,192
Ensembl chr 1:54,542,257...54,639,192
|
|
G |
ACOT12 |
acyl-CoA thioesterase 12 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ACOT12 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:81,308,609...81,394,134
Ensembl chr 5:81,329,996...81,394,179
|
|
G |
ACOX2 |
acyl-CoA oxidase 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ACOX2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:58,505,136...58,537,190
Ensembl chr 3:58,505,136...58,537,283
|
|
G |
ACSL1 |
acyl-CoA synthetase long chain family member 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ACSL1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:184,755,595...184,826,594
Ensembl chr 4:184,755,595...184,826,818
|
|
G |
ACSL4 |
acyl-CoA synthetase long chain family member 4 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ACSL4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr X:109,641,335...109,733,257
Ensembl chr X:109,624,244...109,733,403
|
|
G |
ACSL5 |
acyl-CoA synthetase long chain family member 5 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ACSL5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:112,374,116...112,428,376
Ensembl chr10:112,374,116...112,428,379
|
|
G |
ACSM2A |
acyl-CoA synthetase medium chain family member 2A |
decreases expression |
EXP |
methyleugenol results in decreased expression of ACSM2A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:20,451,521...20,487,669
Ensembl chr16:20,451,461...20,487,669
|
|
G |
ACSM2B |
acyl-CoA synthetase medium chain family member 2B |
decreases expression |
EXP |
methyleugenol results in decreased expression of ACSM2B mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:20,536,226...20,576,367
Ensembl chr16:20,536,226...20,576,427
|
|
G |
ACSM3 |
acyl-CoA synthetase medium chain family member 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ACSM3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:20,674,405...20,797,581
Ensembl chr16:20,610,243...20,797,581
|
|
G |
ACSM5 |
acyl-CoA synthetase medium chain family member 5 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ACSM5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:20,409,534...20,441,336
Ensembl chr16:20,409,534...20,441,336
|
|
G |
ACSS1 |
acyl-CoA synthetase short chain family member 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ACSS1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr20:25,006,237...25,058,139
Ensembl chr20:25,006,230...25,058,980
|
|
G |
ACSS2 |
acyl-CoA synthetase short chain family member 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ACSS2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr20:34,874,989...34,927,959
Ensembl chr20:34,872,146...34,927,962
|
|
G |
ACTL10 |
actin like 10 |
increases expression |
EXP |
methyleugenol results in increased expression of ACTL10 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr20:33,666,943...33,668,525
Ensembl chr20:33,666,943...33,668,525
|
|
G |
ACYP2 |
acylphosphatase 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ACYP2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:53,971,113...54,305,300
Ensembl chr 2:53,970,838...54,305,300
|
|
G |
ADAM19 |
ADAM metallopeptidase domain 19 |
increases expression |
EXP |
methyleugenol results in increased expression of ADAM19 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:157,477,304...157,575,775
Ensembl chr 5:157,395,534...157,575,775
|
|
G |
ADAMTS17 |
ADAM metallopeptidase with thrombospondin type 1 motif 17 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ADAMTS17 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:99,971,437...100,341,975
Ensembl chr15:99,971,437...100,342,005
|
|
G |
ADAMTS3 |
ADAM metallopeptidase with thrombospondin type 1 motif 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ADAMTS3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:72,280,969...72,569,221
Ensembl chr 4:72,280,969...72,569,221
|
|
G |
ADAMTS6 |
ADAM metallopeptidase with thrombospondin type 1 motif 6 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ADAMTS6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:65,148,738...65,481,920
Ensembl chr 5:65,148,738...65,481,920
|
|
G |
ADAMTSL3 |
ADAMTS like 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ADAMTSL3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:83,654,123...84,039,842
Ensembl chr15:83,654,088...84,039,842
|
|
G |
ADARB2 |
adenosine deaminase RNA specific B2 (inactive) |
decreases expression |
EXP |
methyleugenol results in decreased expression of ADARB2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:1,177,313...1,737,525
Ensembl chr10:1,177,313...1,737,525
|
|
G |
ADCY5 |
adenylate cyclase 5 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ADCY5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:123,282,296...123,449,090
Ensembl chr 3:123,282,296...123,449,090
|
|
G |
ADCY8 |
adenylate cyclase 8 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ADCY8 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:130,780,301...131,040,909
Ensembl chr 8:130,780,301...131,040,909
|
|
G |
ADGRF4 |
adhesion G protein-coupled receptor F4 |
increases expression |
EXP |
methyleugenol results in increased expression of ADGRF4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:47,698,580...47,722,014
Ensembl chr 6:47,685,864...47,722,021
|
|
G |
ADGRG1 |
adhesion G protein-coupled receptor G1 |
increases expression |
EXP |
methyleugenol results in increased expression of ADGRG1 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr16:57,619,738...57,665,567
Ensembl chr16:57,610,652...57,665,580
|
|
G |
ADGRG7 |
adhesion G protein-coupled receptor G7 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ADGRG7 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:100,609,601...100,695,479
Ensembl chr 3:100,609,601...100,695,479
|
|
G |
ADGRV1 |
adhesion G protein-coupled receptor V1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ADGRV1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:90,558,797...91,164,437
Ensembl chr 5:90,529,344...91,164,437
|
|
G |
ADH1B |
alcohol dehydrogenase 1B (class I), beta polypeptide |
decreases expression |
EXP |
methyleugenol results in decreased expression of ADH1B mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:99,304,971...99,321,401
Ensembl chr 4:99,304,971...99,321,401
|
|
G |
ADH4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
decreases expression |
EXP |
methyleugenol results in decreased expression of ADH4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:99,123,658...99,144,297
Ensembl chr 4:99,123,657...99,157,792
|
|
G |
ADH6 |
alcohol dehydrogenase 6 (class V) |
decreases expression |
EXP |
methyleugenol results in decreased expression of ADH6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:99,202,639...99,219,246
Ensembl chr 4:99,202,638...99,219,537
|
|
G |
ADK |
adenosine kinase |
decreases expression |
EXP |
methyleugenol results in decreased expression of ADK mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:74,151,221...74,709,290
Ensembl chr10:74,151,202...74,709,963
|
|
G |
ADRA1A |
adrenoceptor alpha 1A |
decreases expression |
EXP |
methyleugenol results in decreased expression of ADRA1A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:26,748,150...26,867,379
Ensembl chr 8:26,748,150...26,867,278
|
|
G |
AFF2 |
ALF transcription elongation factor 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of AFF2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr X:148,500,617...149,000,663
Ensembl chr X:148,500,617...149,000,663
|
|
G |
AFF3 |
ALF transcription elongation factor 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of AFF3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:99,545,419...100,142,590
Ensembl chr 2:99,545,419...100,192,428
|
|
G |
AFG1L |
AFG1 like ATPase |
decreases expression |
EXP |
methyleugenol results in decreased expression of AFG1L mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:108,295,054...108,526,001
Ensembl chr 6:108,294,991...108,526,796
|
|
G |
AFM |
afamin |
decreases expression |
EXP |
methyleugenol results in decreased expression of AFM mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:73,481,745...73,504,001
Ensembl chr 4:73,481,745...73,504,001
|
|
G |
AGBL5-AS1 |
AGBL5 antisense RNA 1 |
increases expression |
EXP |
methyleugenol results in increased expression of AGBL5-AS1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:27,049,683...27,050,264
Ensembl chr 2:27,049,683...27,050,264
|
|
G |
AGMO |
alkylglycerol monooxygenase |
decreases expression |
EXP |
methyleugenol results in decreased expression of AGMO mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:15,117,223...15,562,015
Ensembl chr 7:15,200,317...15,562,015
|
|
G |
AGPAT2 |
1-acylglycerol-3-phosphate O-acyltransferase 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of AGPAT2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:136,673,143...136,687,457
Ensembl chr 9:136,673,143...136,687,457
|
|
G |
AGR2 |
anterior gradient 2, protein disulphide isomerase family member |
increases expression |
EXP |
methyleugenol results in increased expression of AGR2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:16,791,811...16,804,999
Ensembl chr 7:16,791,811...16,833,433
|
|
G |
AGT |
angiotensinogen |
decreases expression |
EXP |
methyleugenol results in decreased expression of AGT mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
|
|
G |
AGXT |
alanine--glyoxylate aminotransferase |
decreases expression |
EXP |
methyleugenol results in decreased expression of AGXT mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:240,868,824...240,880,500
Ensembl chr 2:240,868,824...240,880,502
|
|
G |
AGXT2 |
alanine--glyoxylate aminotransferase 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of AGXT2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:34,998,102...35,047,949
Ensembl chr 5:34,998,101...35,048,135
|
|
G |
AHSG |
alpha 2-HS glycoprotein |
decreases expression |
EXP |
methyleugenol results in decreased expression of AHSG mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:186,613,060...186,621,318
Ensembl chr 3:186,613,060...186,621,318
|
|
G |
AIG1 |
androgen induced 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of AIG1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:143,059,213...143,343,883
Ensembl chr 6:143,060,496...143,341,058
|
|
G |
AKAP12 |
A-kinase anchoring protein 12 |
increases expression |
EXP |
methyleugenol results in increased expression of AKAP12 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:151,239,967...151,358,559
Ensembl chr 6:151,239,967...151,358,559
|
|
G |
AKAP6 |
A-kinase anchoring protein 6 |
decreases expression |
EXP |
methyleugenol results in decreased expression of AKAP6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:32,329,298...32,837,684
Ensembl chr14:32,329,298...32,837,684
|
|
G |
AKR1B1 |
aldo-keto reductase family 1 member B |
increases expression |
EXP |
methyleugenol results in increased expression of AKR1B1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:134,442,350...134,459,239
Ensembl chr 7:134,442,356...134,459,284
|
|
G |
AKR1B10 |
aldo-keto reductase family 1 member B10 |
increases expression |
EXP |
methyleugenol results in increased expression of AKR1B10 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412
|
|
G |
AKR1B15 |
aldo-keto reductase family 1 member B15 |
increases expression |
EXP |
methyleugenol results in increased expression of AKR1B15 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:134,549,110...134,579,869
Ensembl chr 7:134,549,110...134,579,875
|
|
G |
AKR1C4 |
aldo-keto reductase family 1 member C4 |
decreases expression |
EXP |
methyleugenol results in decreased expression of AKR1C4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:5,196,837...5,218,949
Ensembl chr10:5,195,462...5,218,949
|
|
G |
AKR1C6P |
aldo-keto reductase family 1 member C6, pseudogene |
decreases expression |
EXP |
methyleugenol results in decreased expression of AKR1C6P mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:4,871,667...4,916,273
Ensembl chr10:4,871,901...4,891,975
|
|
G |
AKR1D1 |
aldo-keto reductase family 1 member D1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of AKR1D1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:138,076,459...138,118,305
Ensembl chr 7:138,002,324...138,118,305
|
|
G |
AKR7A3 |
aldo-keto reductase family 7 member A3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of AKR7A3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:19,274,229...19,288,770
Ensembl chr 1:19,282,573...19,288,770
|
|
G |
ALB |
albumin |
decreases expression |
EXP |
methyleugenol results in decreased expression of ALB mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
|
|
G |
ALDH3A1 |
aldehyde dehydrogenase 3 family member A1 |
increases expression |
EXP |
methyleugenol results in increased expression of ALDH3A1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:19,737,984...19,748,298
Ensembl chr17:19,737,984...19,748,943
|
|
G |
ALDH4A1 |
aldehyde dehydrogenase 4 family member A1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ALDH4A1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:18,871,430...18,902,555
Ensembl chr 1:18,871,430...18,902,724
|
|
G |
ALDH6A1 |
aldehyde dehydrogenase 6 family member A1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ALDH6A1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:74,056,847...74,084,453
Ensembl chr14:74,056,847...74,084,492
|
|
G |
ALDH8A1 |
aldehyde dehydrogenase 8 family member A1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ALDH8A1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:134,917,393...134,950,101
Ensembl chr 6:134,917,393...134,950,115
|
|
G |
ALDOB |
aldolase, fructose-bisphosphate B |
decreases expression |
EXP |
methyleugenol results in decreased expression of ALDOB mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:101,420,560...101,435,774
Ensembl chr 9:101,420,560...101,449,664
|
|
G |
ALOX5 |
arachidonate 5-lipoxygenase |
increases expression |
EXP |
methyleugenol results in increased expression of ALOX5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119
|
|
G |
ALPK2 |
alpha kinase 2 |
increases expression |
EXP |
methyleugenol results in increased expression of ALPK2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr18:58,481,247...58,629,091
Ensembl chr18:58,481,247...58,629,091
|
|
G |
AMBP |
alpha-1-microglobulin/bikunin precursor |
decreases expression |
EXP |
methyleugenol results in decreased expression of AMBP mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:114,060,127...114,078,300
Ensembl chr 9:114,060,127...114,078,328
|
|
G |
AMOTL1 |
angiomotin like 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of AMOTL1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:94,706,460...94,876,748
Ensembl chr11:94,706,431...94,876,748
|
|
G |
ANG |
angiogenin |
decreases expression |
EXP |
methyleugenol results in decreased expression of ANG mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:20,684,177...20,694,186
Ensembl chr14:20,684,177...20,698,971
|
|
G |
ANGPTL3 |
angiopoietin like 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ANGPTL3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:62,597,520...62,606,313
Ensembl chr 1:62,597,520...62,606,313
|
|
G |
ANGPTL8 |
angiopoietin like 8 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ANGPTL8 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:11,239,619...11,241,943
Ensembl chr19:11,237,502...11,241,943
|
|
G |
ANK1 |
ankyrin 1 |
increases expression |
EXP |
methyleugenol results in increased expression of ANK1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:41,653,225...41,896,741
Ensembl chr 8:41,653,220...41,896,741
|
|
G |
ANK2 |
ankyrin 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ANK2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:112,705,622...113,383,736
Ensembl chr 4:112,818,032...113,384,221
|
|
G |
ANKHD1-EIF4EBP3 |
ANKHD1-EIF4EBP3 readthrough |
decreases expression |
EXP |
methyleugenol results in decreased expression of ANKHD1-EIF4EBP3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:140,401,833...140,549,576
Ensembl chr 5:140,401,908...140,549,569
|
|
G |
ANKRD1 |
ankyrin repeat domain 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ANKRD1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:90,912,096...90,921,087
Ensembl chr10:90,912,096...90,921,087
|
|
G |
ANKRD2 |
ankyrin repeat domain 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ANKRD2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:97,572,441...97,583,884
Ensembl chr10:97,572,499...97,583,884
|
|
G |
ANKS1B |
ankyrin repeat and sterile alpha motif domain containing 1B |
decreases expression |
EXP |
methyleugenol results in decreased expression of ANKS1B mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:98,734,786...99,984,936
Ensembl chr12:98,726,457...99,984,936
|
|
G |
ANO1 |
anoctamin 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ANO1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:69,965,997...70,189,530
Ensembl chr11:69,985,907...70,189,530
|
|
G |
ANO4 |
anoctamin 4 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ANO4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:100,717,261...101,128,641
Ensembl chr12:100,717,526...101,128,641
|
|
G |
ANXA10 |
annexin A10 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ANXA10 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:168,092,537...168,187,736
Ensembl chr 4:168,092,537...168,187,736
|
|
G |
ANXA3 |
annexin A3 |
increases expression |
EXP |
methyleugenol results in increased expression of ANXA3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:78,551,770...78,610,447
Ensembl chr 4:78,551,747...78,610,451
|
|
G |
AOC1 |
amine oxidase copper containing 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of AOC1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:150,852,120...150,861,504
Ensembl chr 7:150,824,627...150,861,504
|
|
G |
AOC4P |
amine oxidase copper containing 4, pseudogene |
decreases expression |
EXP |
methyleugenol results in decreased expression of AOC4P mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:42,867,145...42,869,217
Ensembl chr17:42,865,922...42,874,246 Ensembl chr17:42,865,922...42,874,246
|
|
G |
APBA1 |
amyloid beta precursor protein binding family A member 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of APBA1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:69,427,532...69,673,013
Ensembl chr 9:69,427,532...69,672,371
|
|
G |
APBB1IP |
amyloid beta precursor protein binding family B member 1 interacting protein |
decreases expression |
EXP |
methyleugenol results in decreased expression of APBB1IP mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:26,438,341...26,567,803
Ensembl chr10:26,438,341...26,568,449
|
|
G |
APCDD1L |
APC down-regulated 1 like |
increases expression |
EXP |
methyleugenol results in increased expression of APCDD1L mRNA |
CTD |
PMID:32234424 |
|
NCBI chr20:58,459,101...58,515,399
Ensembl chr20:58,459,101...58,515,399
|
|
G |
APCDD1L-DT |
APCDD1L divergent transcript |
increases expression |
EXP |
methyleugenol results in increased expression of APCDD1L-DT mRNA |
CTD |
PMID:32234424 |
|
NCBI chr20:58,515,379...58,619,892
Ensembl chr20:58,515,379...58,623,080
|
|
G |
APCS |
amyloid P component, serum |
decreases expression |
EXP |
methyleugenol results in decreased expression of APCS mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:159,587,826...159,588,865
Ensembl chr 1:159,587,826...159,588,865
|
|
G |
APMAP |
adipocyte plasma membrane associated protein |
decreases expression |
EXP |
methyleugenol results in decreased expression of APMAP mRNA |
CTD |
PMID:32234424 |
|
NCBI chr20:24,962,925...24,992,751
Ensembl chr20:24,962,925...24,992,751
|
|
G |
APOA1 |
apolipoprotein A1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of APOA1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:116,835,751...116,837,622
Ensembl chr11:116,835,751...116,837,622
|
|
G |
APOA4 |
apolipoprotein A4 |
decreases expression |
EXP |
methyleugenol results in decreased expression of APOA4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:116,820,700...116,823,304
Ensembl chr11:116,820,700...116,823,304
|
|
G |
APOA5 |
apolipoprotein A5 |
decreases expression |
EXP |
methyleugenol results in decreased expression of APOA5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:116,789,367...116,792,420
Ensembl chr11:116,789,367...116,792,420
|
|
G |
APOC3 |
apolipoprotein C3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of APOC3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:116,829,907...116,833,072
Ensembl chr11:116,829,706...116,833,072
|
|
G |
APOH |
apolipoprotein H |
decreases expression |
EXP |
methyleugenol results in decreased expression of APOH mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:66,212,033...66,229,415
Ensembl chr17:66,212,033...66,256,525
|
|
G |
APOM |
apolipoprotein M |
decreases expression |
EXP |
methyleugenol results in decreased expression of APOM mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:31,652,404...31,658,210
Ensembl chr 6:31,652,416...31,658,210
|
|
G |
AQP4 |
aquaporin 4 |
decreases expression |
EXP |
methyleugenol results in decreased expression of AQP4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr18:26,852,038...26,865,803
Ensembl chr18:26,852,043...26,865,771
|
|
G |
AQP4-AS1 |
AQP4 antisense RNA 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of AQP4-AS1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr18:26,865,308...26,935,946
Ensembl chr18:26,655,505...27,190,698
|
|
G |
AQP7P1 |
aquaporin 7 pseudogene 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of AQP7P1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:63,315,243...63,334,520
Ensembl chr 9:63,317,067...63,333,091
|
|
G |
AQP7P2 |
aquaporin 7 pseudogene 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of AQP7P2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:64,621,504...64,639,027
Ensembl chr 9:64,621,560...64,637,586
|
|
G |
AQP7P4 |
aquaporin 7 pseudogene 4 |
decreases expression |
EXP |
methyleugenol results in decreased expression of AQP7P4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:63,133,597...63,143,456
Ensembl chr 9:63,127,359...63,143,401
|
|
G |
AQP9 |
aquaporin 9 |
decreases expression |
EXP |
methyleugenol results in decreased expression of AQP9 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:58,138,169...58,185,911
Ensembl chr15:58,138,169...58,185,911
|
|
G |
ARB2A |
ARB2 cotranscriptional regulator A |
decreases expression |
EXP |
methyleugenol results in decreased expression of ARB2A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:93,617,725...94,111,699
Ensembl chr 5:93,617,725...94,111,699
|
|
G |
ARG1 |
arginase 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ARG1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:131,573,226...131,584,329
Ensembl chr 6:131,470,832...131,584,332
|
|
G |
ARHGAP6 |
Rho GTPase activating protein 6 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ARHGAP6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr X:11,137,544...11,665,920
Ensembl chr X:11,117,651...11,665,920
|
|
G |
ARHGEF37 |
Rho guanine nucleotide exchange factor 37 |
increases expression |
EXP |
methyleugenol results in increased expression of ARHGEF37 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:149,551,625...149,634,968
Ensembl chr 5:149,551,947...149,634,968
|
|
G |
ARL14 |
ADP ribosylation factor like GTPase 14 |
increases expression |
EXP |
methyleugenol results in increased expression of ARL14 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr 3:160,677,160...160,678,448
Ensembl chr 3:160,677,160...160,678,448
|
|
G |
ARRB1 |
arrestin beta 1 |
increases expression |
EXP |
methyleugenol results in increased expression of ARRB1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:75,260,122...75,351,661
Ensembl chr11:75,260,122...75,351,705
|
|
G |
ARSB |
arylsulfatase B |
decreases expression |
EXP |
methyleugenol results in decreased expression of ARSB mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:78,777,209...78,985,958
Ensembl chr 5:78,777,209...78,986,087
|
|
G |
ARSF |
arylsulfatase F |
decreases expression |
EXP |
methyleugenol results in decreased expression of ARSF mRNA |
CTD |
PMID:32234424 |
|
NCBI chr X:3,040,234...3,112,727
Ensembl chr X:3,041,471...3,112,727
|
|
G |
ART3 |
ADP-ribosyltransferase 3 (inactive) |
decreases expression |
EXP |
methyleugenol results in decreased expression of ART3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:76,011,190...76,112,786
Ensembl chr 4:76,011,184...76,114,048
|
|
G |
ARVCF |
ARVCF delta catenin family member |
increases expression |
EXP |
methyleugenol results in increased expression of ARVCF mRNA |
CTD |
PMID:32234424 |
|
NCBI chr22:19,965,134...20,016,823
Ensembl chr22:19,969,896...20,016,823
|
|
G |
ASB4 |
ankyrin repeat and SOCS box containing 4 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ASB4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:95,470,656...95,551,317
Ensembl chr 7:95,478,444...95,540,233
|
|
G |
ASGR1 |
asialoglycoprotein receptor 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ASGR1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:7,173,431...7,179,370
Ensembl chr17:7,173,431...7,179,564
|
|
G |
ASPDH |
aspartate dehydrogenase domain containing |
decreases expression |
EXP |
methyleugenol results in decreased expression of ASPDH mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:50,511,603...50,515,101
Ensembl chr19:50,511,600...50,514,690
|
|
G |
ATL1 |
atlastin GTPase 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ATL1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:50,533,082...50,633,068
Ensembl chr14:50,532,509...50,634,017
|
|
G |
ATM |
ATM serine/threonine kinase |
increases phosphorylation decreases expression |
EXP ISO |
methyleugenol results in increased phosphorylation of ATM protein methyleugenol results in decreased expression of ATM mRNA |
CTD |
PMID:26011634 PMID:28818686 |
|
NCBI chr11:108,223,067...108,369,102
Ensembl chr11:108,222,804...108,369,102
|
|
G |
ATP13A4 |
ATPase 13A4 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ATP13A4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:193,398,967...193,593,119
Ensembl chr 3:193,398,967...193,593,111
|
|
G |
ATP2B2 |
ATPase plasma membrane Ca2+ transporting 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ATP2B2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:10,324,023...10,708,007
Ensembl chr 3:10,324,023...10,708,007
|
|
G |
ATP8B4 |
ATPase phospholipid transporting 8B4 (putative) |
decreases expression |
EXP |
methyleugenol results in decreased expression of ATP8B4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:49,858,238...50,181,854
Ensembl chr15:49,858,238...50,182,817
|
|
G |
ATR |
ATR serine/threonine kinase |
increases phosphorylation |
EXP |
methyleugenol results in increased phosphorylation of ATR protein |
CTD |
PMID:28818686 |
|
NCBI chr 3:142,449,235...142,578,733
Ensembl chr 3:142,449,007...142,578,733
|
|
G |
ATRNL1 |
attractin like 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ATRNL1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:115,093,365...115,948,999
Ensembl chr10:115,093,365...115,948,999
|
|
G |
ATXN1 |
ataxin 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ATXN1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:16,299,112...16,761,460
Ensembl chr 6:16,299,112...16,761,491
|
|
G |
AURKA |
aurora kinase A |
decreases expression |
ISO EXP |
methyleugenol results in decreased expression of AURKA mRNA |
CTD |
PMID:26011634 PMID:32234424 |
|
NCBI chr20:56,369,390...56,392,215
Ensembl chr20:56,369,389...56,392,337
|
|
G |
AURKB |
aurora kinase B |
increases expression affects expression |
ISO |
methyleugenol results in increased expression of AURKB protein methyleugenol affects the expression of AURKB mRNA |
CTD |
PMID:23411599 PMID:26011634 |
|
NCBI chr17:8,204,731...8,210,575
Ensembl chr17:8,204,733...8,210,600
|
|
G |
AZGP1 |
alpha-2-glycoprotein 1, zinc-binding |
decreases expression |
EXP |
methyleugenol results in decreased expression of AZGP1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:99,966,730...99,976,031
Ensembl chr 7:99,966,720...99,976,042
|
|
G |
AZGP1P1 |
AZGP1 pseudogene 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of AZGP1P1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:99,980,762...99,984,237
Ensembl chr 7:99,980,762...99,987,535 Ensembl chr 7:99,980,762...99,987,535
|
|
G |
AZGP1P2 |
AZGP1 pseudogene 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of AZGP1P2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:101,287,479...101,289,775
Ensembl chr 7:101,287,482...101,289,771
|
|
G |
B3GALT1 |
beta-1,3-galactosyltransferase 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of B3GALT1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:167,293,001...167,874,045
Ensembl chr 2:167,293,001...167,874,045
|
|
G |
B3GNT3 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 |
increases expression |
EXP |
methyleugenol results in increased expression of B3GNT3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:17,794,791...17,813,576
Ensembl chr19:17,794,828...17,813,576
|
|
G |
B4GALNT1 |
beta-1,4-N-acetyl-galactosaminyltransferase 1 |
increases expression |
EXP |
methyleugenol results in increased expression of B4GALNT1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:57,623,409...57,633,201
Ensembl chr12:57,623,409...57,633,239
|
|
G |
BAAT |
bile acid-CoA:amino acid N-acyltransferase |
decreases expression |
EXP |
methyleugenol results in decreased expression of BAAT mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:101,360,417...101,385,006
Ensembl chr 9:101,354,182...101,385,400
|
|
G |
BABAM2 |
BRISC and BRCA1 A complex member 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of BABAM2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:27,888,709...28,338,901
Ensembl chr 2:27,889,941...28,338,901
|
|
G |
BAIAP2L2 |
BAR/IMD domain containing adaptor protein 2 like 2 |
increases expression |
EXP |
methyleugenol results in increased expression of BAIAP2L2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr22:38,084,900...38,110,967
Ensembl chr22:38,084,652...38,111,015
|
|
G |
BANF1P2 |
BANF1 pseudogene 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of BANF1P2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:133,344,275...133,344,990
Ensembl chr10:133,344,643...133,344,906
|
|
G |
BANK1 |
B cell scaffold protein with ankyrin repeats 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of BANK1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:101,790,730...102,074,812
Ensembl chr 4:101,411,286...102,074,812
|
|
G |
BATF3 |
basic leucine zipper ATF-like transcription factor 3 |
increases expression |
EXP |
methyleugenol results in increased expression of BATF3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:212,686,417...212,699,840
Ensembl chr 1:212,686,417...212,699,840
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
increases expression |
EXP |
methyleugenol results in increased expression of BAX mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BBOX1 |
gamma-butyrobetaine hydroxylase 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of BBOX1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:27,040,815...27,127,809
Ensembl chr11:27,040,725...27,127,809
|
|
G |
BBS9 |
Bardet-Biedl syndrome 9 |
decreases expression |
EXP |
methyleugenol results in decreased expression of BBS9 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:33,129,285...33,635,767
Ensembl chr 7:33,109,557...33,877,180
|
|
G |
BCAS3 |
BCAS3 microtubule associated cell migration factor |
decreases expression |
EXP |
methyleugenol results in decreased expression of BCAS3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:60,677,851...61,392,831
Ensembl chr17:60,677,453...61,392,838
|
|
G |
BCKDHB |
branched chain keto acid dehydrogenase E1 subunit beta |
decreases expression |
EXP |
methyleugenol results in decreased expression of BCKDHB mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:80,106,610...80,466,676
Ensembl chr 6:80,106,647...80,346,270
|
|
G |
BCL2L15 |
BCL2 like 15 |
increases expression |
EXP |
methyleugenol results in increased expression of BCL2L15 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:113,876,816...113,887,581
Ensembl chr 1:113,876,816...113,887,581
|
|
G |
BDH1 |
3-hydroxybutyrate dehydrogenase 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of BDH1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:197,509,783...197,573,343
Ensembl chr 3:197,509,783...197,573,323
|
|
G |
BDKRB2 |
bradykinin receptor B2 |
increases expression |
EXP |
methyleugenol results in increased expression of BDKRB2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:96,204,839...96,244,164
Ensembl chr14:96,204,679...96,244,166
|
|
G |
BHLHE40-AS1 |
BHLHE40 antisense RNA 1 |
increases expression |
EXP |
methyleugenol results in increased expression of BHLHE40-AS1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:4,896,809...4,979,961
Ensembl chr 3:4,896,806...4,980,414
|
|
G |
BHLHE41 |
basic helix-loop-helix family member e41 |
increases expression |
EXP |
methyleugenol results in increased expression of BHLHE41 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:26,120,030...26,125,037
Ensembl chr12:26,120,030...26,125,037
|
|
G |
BHMT |
betaine--homocysteine S-methyltransferase |
decreases expression |
EXP |
methyleugenol results in decreased expression of BHMT mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:79,111,809...79,132,288
Ensembl chr 5:79,111,809...79,132,288
|
|
G |
BMERB1 |
bMERB domain containing 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of BMERB1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:15,434,588...15,588,259
Ensembl chr16:15,434,475...15,625,028
|
|
G |
BMF |
Bcl2 modifying factor |
increases expression |
EXP |
methyleugenol results in increased expression of BMF mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:40,087,890...40,108,879
Ensembl chr15:40,087,890...40,108,892
|
|
G |
BMPR1B |
bone morphogenetic protein receptor type 1B |
decreases expression |
EXP |
methyleugenol results in decreased expression of BMPR1B mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:94,757,955...95,158,450
Ensembl chr 4:94,757,955...95,158,448
|
|
G |
BRCA1 |
BRCA1 DNA repair associated |
decreases expression |
ISO |
methyleugenol results in decreased expression of BRCA1 mRNA |
CTD |
PMID:21659616 PMID:26011634 |
|
NCBI chr17:43,044,295...43,170,327
Ensembl chr17:43,044,295...43,170,245
|
|
G |
BRCA2 |
BRCA2 DNA repair associated |
decreases expression |
ISO |
methyleugenol results in decreased expression of BRCA2 mRNA |
CTD |
PMID:26011634 |
|
NCBI chr13:32,315,077...32,400,268
Ensembl chr13:32,315,086...32,400,268
|
|
G |
BRCC3 |
BRCA1/BRCA2-containing complex subunit 3 |
affects expression |
ISO |
methyleugenol affects the expression of BRCC3 mRNA |
CTD |
PMID:26011634 |
|
NCBI chr X:155,071,508...155,123,077
Ensembl chr X:155,071,420...155,123,077
|
|
G |
BRINP1 |
BMP/retinoic acid inducible neural specific 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of BRINP1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:119,166,629...119,369,435
Ensembl chr 9:119,153,458...119,369,435
|
|
G |
BSN |
bassoon presynaptic cytomatrix protein |
decreases expression |
EXP |
methyleugenol results in decreased expression of BSN mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:49,554,477...49,673,130
Ensembl chr 3:49,554,477...49,671,549
|
|
G |
BTBD16 |
BTB domain containing 16 |
decreases expression |
EXP |
methyleugenol results in decreased expression of BTBD16 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:122,271,296...122,338,159
Ensembl chr10:122,271,296...122,338,159
|
|
G |
BTBD9 |
BTB domain containing 9 |
decreases expression |
EXP |
methyleugenol results in decreased expression of BTBD9 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:38,168,451...38,639,929
Ensembl chr 6:38,168,451...38,640,148
|
|
G |
BUB1 |
BUB1 mitotic checkpoint serine/threonine kinase |
increases expression |
ISO |
methyleugenol results in increased expression of BUB1 mRNA |
CTD |
PMID:26011634 |
|
NCBI chr 2:110,637,528...110,678,063
Ensembl chr 2:110,637,528...110,678,063
|
|
G |
C11orf54 |
chromosome 11 open reading frame 54 |
decreases expression |
EXP |
methyleugenol results in decreased expression of C11ORF54 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:93,741,672...93,764,749
Ensembl chr11:93,741,591...93,764,749
|
|
G |
C11orf65 |
chromosome 11 open reading frame 65 |
decreases expression |
EXP |
methyleugenol results in decreased expression of C11ORF65 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:108,308,519...108,469,881
Ensembl chr11:108,308,519...108,467,531
|
|
G |
C11orf86 |
chromosome 11 open reading frame 86 |
decreases expression |
EXP |
methyleugenol results in decreased expression of C11ORF86 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:66,975,304...66,977,009
Ensembl chr11:66,975,277...66,977,009
|
|
G |
C1orf226 |
chromosome 1 open reading frame 226 |
decreases expression |
EXP |
methyleugenol results in decreased expression of C1ORF226 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:162,378,841...162,386,812
Ensembl chr 1:162,378,841...162,386,812
|
|
G |
C2CD4A |
C2 calcium dependent domain containing 4A |
increases expression |
EXP |
methyleugenol results in increased expression of C2CD4A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:62,066,977...62,070,917
Ensembl chr15:62,066,977...62,070,917
|
|
G |
C3P1 |
complement component 3 precursor pseudogene |
decreases expression |
EXP |
methyleugenol results in decreased expression of C3P1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:10,041,356...10,074,138
Ensembl chr19:10,037,803...10,074,135 Ensembl chr19:10,037,803...10,074,135
|
|
G |
C4BPA |
complement component 4 binding protein alpha |
decreases expression |
EXP |
methyleugenol results in decreased expression of C4BPA mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:207,104,233...207,144,972
Ensembl chr 1:207,104,233...207,144,972
|
|
G |
C4BPB |
complement component 4 binding protein beta |
decreases expression |
EXP |
methyleugenol results in decreased expression of C4BPB mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:207,088,860...207,099,993
Ensembl chr 1:207,088,860...207,099,993
|
|
G |
C5 |
complement C5 |
decreases expression |
EXP |
methyleugenol results in decreased expression of C5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:120,952,335...121,074,865
Ensembl chr 9:120,932,987...121,075,195
|
|
G |
C6 |
complement C6 |
decreases expression |
EXP |
methyleugenol results in decreased expression of C6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:41,142,116...41,261,469
Ensembl chr 5:41,142,116...41,261,438
|
|
G |
C6orf141 |
chromosome 6 open reading frame 141 |
increases expression |
EXP |
methyleugenol results in increased expression of C6ORF141 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:49,550,668...49,561,916
Ensembl chr 6:49,550,666...49,561,907
|
|
G |
C8A |
complement C8 alpha chain |
decreases expression |
EXP |
methyleugenol results in decreased expression of C8A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:56,854,797...56,918,223
Ensembl chr 1:56,854,768...56,918,223
|
|
G |
C8B |
complement C8 beta chain |
decreases expression |
EXP |
methyleugenol results in decreased expression of C8B mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:56,929,207...56,966,015
Ensembl chr 1:56,929,207...56,974,383
|
|
G |
C8G |
complement C8 gamma chain |
decreases expression |
EXP |
methyleugenol results in decreased expression of C8G mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:136,945,243...136,946,975
Ensembl chr 9:136,945,185...136,946,975
|
|
G |
C9 |
complement C9 |
decreases expression |
EXP |
methyleugenol results in decreased expression of C9 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:39,284,140...39,364,495
Ensembl chr 5:39,284,140...39,371,324
|
|
G |
CA12 |
carbonic anhydrase 12 |
increases expression |
EXP |
methyleugenol results in increased expression of CA12 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:63,321,378...63,381,846
Ensembl chr15:63,321,378...63,381,846
|
|
G |
CA3 |
carbonic anhydrase 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CA3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:85,438,859...85,449,040
Ensembl chr 8:85,373,436...85,449,040
|
|
G |
CA9 |
carbonic anhydrase 9 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CA9 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:35,673,928...35,681,159
Ensembl chr 9:35,673,928...35,681,159
|
|
G |
CACNA1D |
calcium voltage-gated channel subunit alpha1 D |
decreases expression |
EXP |
methyleugenol results in decreased expression of CACNA1D mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:53,494,611...53,813,733
Ensembl chr 3:53,328,963...53,813,733
|
|
G |
CACNA2D1 |
calcium voltage-gated channel auxiliary subunit alpha2delta 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CACNA2D1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:81,946,444...82,443,956
Ensembl chr 7:81,946,444...82,443,956
|
|
G |
CACNA2D3 |
calcium voltage-gated channel auxiliary subunit alpha2delta 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CACNA2D3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:54,122,552...55,074,557
Ensembl chr 3:54,122,552...55,074,557
|
|
G |
CACNB3 |
calcium voltage-gated channel auxiliary subunit beta 3 |
increases expression |
EXP |
methyleugenol results in increased expression of CACNB3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:48,814,480...48,828,941
Ensembl chr12:48,813,794...48,828,941
|
|
G |
CADM2 |
cell adhesion molecule 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CADM2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:84,958,989...86,074,429
Ensembl chr 3:84,958,989...86,074,429
|
|
G |
CADPS2 |
calcium dependent secretion activator 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CADPS2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:122,318,411...122,886,460
Ensembl chr 7:122,318,411...122,886,759
|
|
G |
CALB2 |
calbindin 2 |
increases expression |
EXP |
methyleugenol results in increased expression of CALB2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:71,358,723...71,390,433
Ensembl chr16:71,358,713...71,390,436
|
|
G |
CALML4 |
calmodulin like 4 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CALML4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:68,190,705...68,206,110
Ensembl chr15:68,190,705...68,206,079
|
|
G |
CALN1 |
calneuron 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CALN1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:71,779,491...72,504,279
Ensembl chr 7:71,779,491...72,447,151
|
|
G |
CAMK1D |
calcium/calmodulin dependent protein kinase ID |
decreases expression |
EXP |
methyleugenol results in decreased expression of CAMK1D mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:12,349,547...12,835,545
Ensembl chr10:12,349,547...12,835,545
|
|
G |
CAMK4 |
calcium/calmodulin dependent protein kinase IV |
decreases expression |
EXP |
methyleugenol results in decreased expression of CAMK4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:111,223,583...111,494,886
Ensembl chr 5:111,223,653...111,494,886
|
|
G |
CARMIL3 |
capping protein regulator and myosin 1 linker 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CARMIL3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:24,052,009...24,069,729
Ensembl chr14:24,052,009...24,069,729
|
|
G |
CASP16P |
caspase 16, pseudogene |
decreases expression |
EXP |
methyleugenol results in decreased expression of CASP16P mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:3,144,291...3,149,946
Ensembl chr16:3,144,015...3,149,808
|
|
G |
CASP3 |
caspase 3 |
increases activity increases cleavage |
EXP ISO |
methyleugenol results in increased activity of CASP3 protein methyleugenol results in increased cleavage of CASP3 protein |
CTD |
PMID:26011634 PMID:28818686 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CAT |
catalase |
decreases expression |
EXP |
methyleugenol results in decreased expression of CAT mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CATSPER3 |
cation channel sperm associated 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CATSPER3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:134,967,907...135,011,696
Ensembl chr 5:134,967,907...135,011,696
|
|
G |
CATSPERE |
catsper channel auxiliary subunit epsilon |
decreases expression |
EXP |
methyleugenol results in decreased expression of CATSPERE mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:244,451,242...244,640,504
Ensembl chr 1:244,454,377...244,641,177
|
|
G |
CBARP |
CACN subunit beta associated regulatory protein |
decreases expression |
EXP |
methyleugenol results in decreased expression of CBARP mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:1,228,287...1,238,502
Ensembl chr19:1,228,287...1,238,027
|
|
G |
CBR3 |
carbonyl reductase 3 |
increases expression |
EXP |
methyleugenol results in increased expression of CBR3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr21:36,135,079...36,146,562
Ensembl chr21:36,135,079...36,146,562
|
|
G |
CBX5 |
chromobox 5 |
increases expression |
ISO |
methyleugenol results in increased expression of CBX5 protein |
CTD |
PMID:23411599 |
|
NCBI chr12:54,230,942...54,280,122
Ensembl chr12:54,230,942...54,280,133
|
|
G |
CCBE1 |
collagen and calcium binding EGF domains 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CCBE1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr18:59,430,939...59,697,721
Ensembl chr18:59,430,939...59,697,662
|
|
G |
CCDC13-AS2 |
CCDC13 antisense RNA 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CCDC13-AS2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:42,770,612...42,773,635
Ensembl chr 3:42,770,562...42,773,795
|
|
G |
CCDC141 |
coiled-coil domain containing 141 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CCDC141 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:178,814,978...179,050,137
Ensembl chr 2:178,829,757...179,050,137
|
|
G |
CCDC146 |
coiled-coil domain containing 146 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CCDC146 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:77,122,615...77,295,204
Ensembl chr 7:77,122,434...77,329,533
|
|
G |
CCDC170 |
coiled-coil domain containing 170 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CCDC170 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:151,494,017...151,621,193
Ensembl chr 6:151,494,017...151,621,193
|
|
G |
CCDC171 |
coiled-coil domain containing 171 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CCDC171 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:15,552,885...16,108,926
Ensembl chr 9:15,553,043...16,061,663
|
|
G |
CCL16 |
C-C motif chemokine ligand 16 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CCL16 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:35,976,499...35,981,497
Ensembl chr17:35,976,493...35,981,497
|
|
G |
CCN2 |
cellular communication network factor 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CCN2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372
|
|
G |
CCNB1 |
cyclin B1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CCNB1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
|
|
G |
CCNG1 |
cyclin G1 |
increases expression |
ISO |
methyleugenol results in increased expression of CCNG1 mRNA |
CTD |
PMID:15618236 |
|
NCBI chr 5:163,437,571...163,457,640
Ensembl chr 5:163,437,569...163,448,199
|
|
G |
CCRL2 |
C-C motif chemokine receptor like 2 |
increases expression |
EXP |
methyleugenol results in increased expression of CCRL2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:46,407,259...46,409,523
Ensembl chr 3:46,407,166...46,412,997
|
|
G |
CCSER1 |
coiled-coil serine rich protein 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CCSER1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:90,127,394...91,605,295
Ensembl chr 4:90,127,394...91,605,295
|
|
G |
CD22 |
CD22 molecule |
increases expression |
EXP |
methyleugenol results in increased expression of CD22 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:35,329,187...35,347,361
Ensembl chr19:35,319,261...35,347,361
|
|
G |
CD44 |
CD44 molecule (IN blood group) |
increases expression |
EXP |
methyleugenol results in increased expression of CD44 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:35,139,171...35,232,402
Ensembl chr11:35,138,882...35,232,402
|
|
G |
CD9 |
CD9 molecule |
increases expression |
EXP |
methyleugenol results in increased expression of CD9 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:6,199,946...6,238,266
Ensembl chr12:6,199,715...6,238,271
|
|
G |
CDC14A |
cell division cycle 14A |
decreases expression |
EXP |
methyleugenol results in decreased expression of CDC14A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:100,345,001...100,520,277
Ensembl chr 1:100,325,629...100,520,277
|
|
G |
CDC20B |
cell division cycle 20B |
decreases expression |
EXP |
methyleugenol results in decreased expression of CDC20B mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:55,112,971...55,173,177
Ensembl chr 5:55,112,971...55,173,177
|
|
G |
CDCA3 |
cell division cycle associated 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CDCA3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:6,844,798...6,851,286
Ensembl chr12:6,844,793...6,851,292
|
|
G |
CDH1 |
cadherin 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CDH1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
|
|
G |
CDH12 |
cadherin 12 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CDH12 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:21,750,673...22,853,344
Ensembl chr 5:21,750,673...22,853,344
|
|
G |
CDK1 |
cyclin dependent kinase 1 |
increases expression |
ISO |
methyleugenol results in increased expression of CDK1 protein |
CTD |
PMID:23411599 |
|
NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
|
|
G |
CDK14 |
cyclin dependent kinase 14 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CDK14 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:90,596,321...91,210,590
Ensembl chr 7:90,466,424...91,210,590
|
|
G |
CDK2AP2 |
cyclin dependent kinase 2 associated protein 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CDK2AP2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:67,506,497...67,508,162
Ensembl chr11:67,506,497...67,508,649
|
|
G |
CDKAL1 |
CDK5 regulatory subunit associated protein 1 like 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CDKAL1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:20,534,457...21,232,404
Ensembl chr 6:20,534,457...21,232,404
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
increases expression increases phosphorylation |
ISO |
methyleugenol results in increased expression of CDKN1A mRNA methyleugenol results in increased expression of CDKN1A mRNA; methyleugenol results in increased expression of CDKN1A protein methyleugenol results in increased phosphorylation of CDKN1A protein |
CTD |
PMID:15618236 PMID:23411599 PMID:26011634 |
|
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,397
|
|
G |
CDKN2A |
cyclin dependent kinase inhibitor 2A |
increases expression decreases expression |
ISO |
methyleugenol results in increased expression of CDKN2A protein methyleugenol results in decreased expression of CDKN2A mRNA |
CTD |
PMID:23411599 PMID:26011634 |
|
NCBI chr 9:21,967,752...21,995,324
Ensembl chr 9:21,967,752...21,995,301
|
|
G |
CDO1 |
cysteine dioxygenase type 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CDO1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:115,804,733...115,816,659
Ensembl chr 5:115,804,733...115,816,659
|
|
G |
CDR2L |
cerebellar degeneration related protein 2 like |
increases expression |
EXP |
methyleugenol results in increased expression of CDR2L mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:74,987,632...75,005,800
Ensembl chr17:74,987,632...75,005,800
|
|
G |
CEACAM1 |
CEA cell adhesion molecule 1 |
increases expression |
EXP |
methyleugenol results in increased expression of CEACAM1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:42,507,306...42,528,481
Ensembl chr19:42,507,304...42,561,234
|
|
G |
CEACAM20 |
CEA cell adhesion molecule 20 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CEACAM20 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:44,506,159...44,529,675
Ensembl chr19:44,501,677...44,529,788
|
|
G |
CEMIP |
cell migration inducing hyaluronidase 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CEMIP mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:80,779,370...80,951,771
Ensembl chr15:80,779,343...80,951,776
|
|
G |
CENPA |
centromere protein A |
decreases expression |
EXP |
methyleugenol results in decreased expression of CENPA mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:26,786,056...26,794,589
Ensembl chr 2:26,764,289...26,801,067
|
|
G |
CENPE |
centromere protein E |
decreases expression |
EXP |
methyleugenol results in decreased expression of CENPE mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:103,105,811...103,198,343
Ensembl chr 4:103,105,349...103,198,445
|
|
G |
CEP128 |
centrosomal protein 128 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CEP128 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:80,476,969...80,959,502
Ensembl chr14:80,476,983...80,959,517
|
|
G |
CES3 |
carboxylesterase 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CES3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:66,961,266...66,975,149
Ensembl chr16:66,961,245...66,975,149
|
|
G |
CFAP20DC |
CFAP20 domain containing |
decreases expression |
EXP |
methyleugenol results in decreased expression of CFAP20DC mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:58,716,173...59,050,025
Ensembl chr 3:58,717,365...59,050,084
|
|
G |
CFAP418-AS1 |
CFAP418 antisense RNA 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CFAP418-AS1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:95,268,836...95,810,143
Ensembl chr 8:95,204,456...95,811,254
|
|
G |
CFAP52 |
cilia and flagella associated protein 52 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CFAP52 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:9,576,642...9,645,554
Ensembl chr17:9,576,627...9,643,447
|
|
G |
CFB |
complement factor B |
decreases expression |
EXP |
methyleugenol results in decreased expression of CFB mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:31,946,095...31,952,084
Ensembl chr 6:31,945,650...31,952,086
|
|
G |
CFHR1 |
complement factor H related 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CFHR1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:196,819,731...196,832,189
Ensembl chr 1:196,819,731...196,837,159
|
|
G |
CFHR2 |
complement factor H related 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CFHR2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:196,943,738...196,959,622
Ensembl chr 1:196,943,738...196,959,622
|
|
G |
CFHR3 |
complement factor H related 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CFHR3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:196,774,840...196,795,407
Ensembl chr 1:196,774,813...196,795,407
|
|
G |
CFHR4 |
complement factor H related 4 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CFHR4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:196,888,052...196,918,633
Ensembl chr 1:196,888,014...196,918,795
|
|
G |
CFHR5 |
complement factor H related 5 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CFHR5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:196,975,034...197,009,678
Ensembl chr 1:196,975,010...197,009,678
|
|
G |
CHEK1 |
checkpoint kinase 1 |
affects expression |
ISO |
methyleugenol affects the expression of CHEK1 mRNA |
CTD |
PMID:26011634 |
|
NCBI chr11:125,625,136...125,681,124
Ensembl chr11:125,625,163...125,676,255
|
|
G |
CHEK2 |
checkpoint kinase 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CHEK2 mRNA |
CTD |
PMID:26011634 |
|
NCBI chr22:28,687,743...28,741,834
Ensembl chr22:28,687,743...28,742,422
|
|
G |
CHN2 |
chimerin 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CHN2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:29,146,591...29,514,328
Ensembl chr 7:29,146,547...29,514,328
|
|
G |
CIDEB |
cell death inducing DFFA like effector b |
decreases expression |
EXP |
methyleugenol results in decreased expression of CIDEB mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:24,305,187...24,311,435
Ensembl chr14:24,305,187...24,311,430
|
|
G |
CISH |
cytokine inducible SH2 containing protein |
decreases expression |
ISO |
methyleugenol results in decreased expression of CISH mRNA |
CTD |
PMID:15618236 |
|
NCBI chr 3:50,606,489...50,611,774
Ensembl chr 3:50,606,489...50,611,774
|
|
G |
CLCNKA |
chloride voltage-gated channel Ka |
decreases expression |
EXP |
methyleugenol results in decreased expression of CLCNKA mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:16,022,036...16,034,050
Ensembl chr 1:16,018,875...16,034,050
|
|
G |
CLDN14 |
claudin 14 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CLDN14 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr21:36,460,621...36,576,569
Ensembl chr21:36,460,621...36,576,569
|
|
G |
CLDN16 |
claudin 16 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CLDN16 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:190,290,361...190,412,138
Ensembl chr 3:190,322,541...190,412,138
|
|
G |
CLRN3 |
clarin 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CLRN3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:127,877,841...127,892,941
Ensembl chr10:127,877,841...127,892,941
|
|
G |
CLYBL |
citramalyl-CoA lyase |
decreases expression |
EXP |
methyleugenol results in decreased expression of CLYBL mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:99,606,690...99,909,444
Ensembl chr13:99,606,669...99,909,459
|
|
G |
CMSS1 |
cms1 ribosomal small subunit homolog |
decreases expression |
EXP |
methyleugenol results in decreased expression of CMSS1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:99,817,862...100,181,732
Ensembl chr 3:99,817,837...100,181,732
|
|
G |
CNGA1 |
cyclic nucleotide gated channel subunit alpha 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CNGA1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:47,935,977...48,016,681
Ensembl chr 4:47,935,977...48,016,681
|
|
G |
CNKSR2 |
connector enhancer of kinase suppressor of Ras 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CNKSR2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr X:21,374,418...21,654,689
Ensembl chr X:21,372,801...21,654,695
|
|
G |
CNN2P3 |
calponin 2 pseudogene 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CNN2P3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:64,485,967...64,487,107
Ensembl chr 9:64,486,164...64,487,069
|
|
G |
CNTN1 |
contactin 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CNTN1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:40,692,439...41,072,415
Ensembl chr12:40,692,439...41,072,415
|
|
G |
CNTN5 |
contactin 5 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CNTN5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:99,020,949...100,358,885
Ensembl chr11:99,020,949...100,358,885
|
|
G |
COBL |
cordon-bleu WH2 repeat protein |
decreases expression |
EXP |
methyleugenol results in decreased expression of COBL mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:51,016,212...51,316,809
Ensembl chr 7:51,016,212...51,316,818
|
|
G |
COL18A1 |
collagen type XVIII alpha 1 chain |
decreases expression |
EXP |
methyleugenol results in decreased expression of COL18A1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr21:45,405,165...45,513,720
Ensembl chr21:45,405,165...45,513,720
|
|
G |
COL5A2 |
collagen type V alpha 2 chain |
decreases expression |
EXP |
methyleugenol results in decreased expression of COL5A2 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr 2:189,031,898...189,441,111
Ensembl chr 2:189,031,898...189,225,312
|
|
G |
COL8A1 |
collagen type VIII alpha 1 chain |
decreases expression |
EXP |
methyleugenol results in decreased expression of COL8A1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:99,638,594...99,799,217
Ensembl chr 3:99,638,475...99,799,226
|
|
G |
COMMD1 |
copper metabolism domain containing 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of COMMD1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:61,888,391...62,136,058
Ensembl chr 2:61,888,724...62,147,247
|
|
G |
COMMD10 |
COMM domain containing 10 |
decreases expression |
EXP |
methyleugenol results in decreased expression of COMMD10 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:116,085,025...116,293,287
Ensembl chr 5:116,085,016...116,412,762
|
|
G |
COX6A2 |
cytochrome c oxidase subunit 6A2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of COX6A2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:31,427,731...31,428,360
Ensembl chr16:31,427,731...31,428,360
|
|
G |
CPA4 |
carboxypeptidase A4 |
increases expression |
EXP |
methyleugenol results in increased expression of CPA4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:130,293,161...130,324,180
Ensembl chr 7:130,293,134...130,324,180
|
|
G |
CPA5 |
carboxypeptidase A5 |
increases expression |
EXP |
methyleugenol results in increased expression of CPA5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:130,344,816...130,374,599
Ensembl chr 7:130,344,816...130,368,730
|
|
G |
CPB2 |
carboxypeptidase B2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CPB2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:46,053,186...46,105,033
Ensembl chr13:46,053,186...46,105,033
|
|
G |
CPB2-AS1 |
CPB2 antisense RNA 1 |
increases expression |
EXP |
methyleugenol results in increased expression of CPB2-AS1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:46,052,848...46,101,347
Ensembl chr13:46,052,497...46,161,379
|
|
G |
CPED1 |
cadherin like and PC-esterase domain containing 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CPED1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:120,988,711...121,297,442
Ensembl chr 7:120,988,697...121,297,442
|
|
G |
CPLX1 |
complexin 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CPLX1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:784,957...826,129
Ensembl chr 4:784,957...826,129
|
|
G |
CPN1 |
carboxypeptidase N subunit 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CPN1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:100,042,193...100,081,869
Ensembl chr10:100,042,193...100,081,869
|
|
G |
CPNE2 |
copine 2 |
increases expression |
EXP |
methyleugenol results in increased expression of CPNE2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:57,092,583...57,148,369
Ensembl chr16:57,092,583...57,148,369
|
|
G |
CPNE4 |
copine 4 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CPNE4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:131,533,569...132,039,606
Ensembl chr 3:131,533,555...132,285,410
|
|
G |
CPNE6 |
copine 6 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CPNE6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:24,070,949...24,078,087
Ensembl chr14:24,070,837...24,078,100
|
|
G |
CPQ |
carboxypeptidase Q |
decreases expression |
EXP |
methyleugenol results in decreased expression of CPQ mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:96,645,242...97,143,501
Ensembl chr 8:96,645,242...97,149,654
|
|
G |
CPS1 |
carbamoyl-phosphate synthase 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CPS1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:210,477,685...210,679,107
Ensembl chr 2:210,477,682...210,679,107
|
|
G |
CPVL |
carboxypeptidase vitellogenic like |
decreases expression |
EXP |
methyleugenol results in decreased expression of CPVL mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:28,994,636...29,195,451
Ensembl chr 7:28,995,235...29,195,451
|
|
G |
CRB1 |
crumbs cell polarity complex component 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CRB1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:197,201,504...197,478,455
Ensembl chr 1:197,268,204...197,478,455
|
|
G |
CRELD2 |
cysteine rich with EGF like domains 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CRELD2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr22:49,918,634...49,927,537
Ensembl chr22:49,918,167...49,927,540
|
|
G |
CRP |
C-reactive protein |
decreases expression |
EXP |
methyleugenol results in decreased expression of CRP mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
|
|
G |
CRPPA |
CDP-L-ribitol pyrophosphorylase A |
decreases expression |
EXP |
methyleugenol results in decreased expression of CRPPA mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:16,087,525...16,421,538
Ensembl chr 7:16,087,525...16,502,504
|
|
G |
CRYBG2 |
crystallin beta-gamma domain containing 2 |
increases expression |
EXP |
methyleugenol results in increased expression of CRYBG2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:26,321,865...26,354,130
Ensembl chr 1:26,321,698...26,360,080
|
|
G |
CTH |
cystathionine gamma-lyase |
decreases expression |
EXP |
methyleugenol results in decreased expression of CTH mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:70,411,268...70,439,851
Ensembl chr 1:70,411,218...70,439,851
|
|
G |
CTNNA3 |
catenin alpha 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CTNNA3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:65,912,523...67,763,594
Ensembl chr10:65,912,457...67,763,637
|
|
G |
CTNNB1 |
catenin beta 1 |
increases mutagenesis |
ISO |
methyleugenol results in increased mutagenesis of CTNNB1 gene |
CTD |
PMID:10467420 |
|
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
|
|
G |
CTXN1 |
cortexin 1 |
increases expression |
EXP |
methyleugenol results in increased expression of CTXN1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:7,924,491...7,926,135
Ensembl chr19:7,924,491...7,926,135
|
|
G |
CUX2 |
cut like homeobox 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CUX2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:111,034,165...111,350,554
Ensembl chr12:111,034,165...111,350,554
|
|
G |
CX3CR1 |
C-X3-C motif chemokine receptor 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CX3CR1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:39,263,494...39,292,966
Ensembl chr 3:39,263,495...39,281,735
|
|
G |
CXCL13 |
C-X-C motif chemokine ligand 13 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CXCL13 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:77,511,753...77,611,834
Ensembl chr 4:77,511,753...77,611,834
|
|
G |
CXXC4 |
CXXC finger protein 4 |
increases expression |
EXP |
methyleugenol results in increased expression of CXXC4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:104,468,308...104,494,894
Ensembl chr 4:104,468,308...104,494,901
|
|
G |
CYBA |
cytochrome b-245 alpha chain |
decreases expression |
EXP |
methyleugenol results in decreased expression of CYBA mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr16:88,643,289...88,651,053
Ensembl chr16:88,643,275...88,651,083
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
increases expression |
EXP |
methyleugenol results in increased expression of CYP1A1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP1A2 |
cytochrome P450 family 1 subfamily A member 2 |
increases expression |
EXP |
methyleugenol results in increased expression of CYP1A2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
|
|
G |
CYP1B1 |
cytochrome P450 family 1 subfamily B member 1 |
increases expression |
EXP |
methyleugenol results in increased expression of CYP1B1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
|
|
G |
CYP2A13 |
cytochrome P450 family 2 subfamily A member 13 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CYP2A13 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:41,088,451...41,096,195
Ensembl chr19:41,088,451...41,096,195
|
|
G |
CYP2A6 |
cytochrome P450 family 2 subfamily A member 6 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CYP2A6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447
|
|
G |
CYP2A7 |
cytochrome P450 family 2 subfamily A member 7 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CYP2A7 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:40,875,439...40,882,231
Ensembl chr19:40,875,439...40,882,752
|
|
G |
CYP2B6 |
cytochrome P450 family 2 subfamily B member 6 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CYP2B6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
|
|
G |
CYP2B7P |
cytochrome P450 family 2 subfamily B member 7, pseudogene |
decreases expression |
EXP |
methyleugenol results in decreased expression of CYP2B7P mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:40,924,265...40,950,660
Ensembl chr19:40,924,273...40,949,234 Ensembl chr19:40,924,273...40,949,234
|
|
G |
CYP2C19 |
cytochrome P450 family 2 subfamily C member 19 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CYP2C19 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
|
|
G |
CYP2C8 |
cytochrome P450 family 2 subfamily C member 8 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CYP2C8 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:95,036,772...95,069,497
Ensembl chr10:95,036,772...95,069,497
|
|
G |
CYP2C9 |
cytochrome P450 family 2 subfamily C member 9 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CYP2C9 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091
|
|
G |
CYP2D6 |
cytochrome P450 family 2 subfamily D member 6 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CYP2D6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865
|
|
G |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CYP2E1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
|
|
G |
CYP2U1-AS1 |
CYP2U1 and SGMS2 antisense RNA 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CYP2U1-AS1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:107,863,479...107,932,119
Ensembl chr 4:107,863,473...107,989,761
|
|
G |
CYP3A7 |
cytochrome P450 family 3 subfamily A member 7 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CYP3A7 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:99,705,036...99,735,196
Ensembl chr 7:99,705,036...99,735,196
|
|
G |
CYP46A1 |
cytochrome P450 family 46 subfamily A member 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CYP46A1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:99,684,298...99,727,301
Ensembl chr14:99,684,298...99,727,301
|
|
G |
CYP4A11 |
cytochrome P450 family 4 subfamily A member 11 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CYP4A11 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:46,929,188...46,941,476
Ensembl chr 1:46,929,177...46,941,484
|
|
G |
CYP4A22 |
cytochrome P450 family 4 subfamily A member 22 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CYP4A22 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:47,137,441...47,149,727
Ensembl chr 1:47,137,435...47,149,727
|
|
G |
CYP4B1 |
cytochrome P450 family 4 subfamily B member 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CYP4B1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:46,799,046...46,819,413
Ensembl chr 1:46,757,838...46,819,413
|
|
G |
CYP4F2 |
cytochrome P450 family 4 subfamily F member 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CYP4F2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:15,878,023...15,898,074
Ensembl chr19:15,878,023...15,898,077
|
|
G |
CYP4X1 |
cytochrome P450 family 4 subfamily X member 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CYP4X1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:46,961,364...47,055,432
Ensembl chr 1:47,023,669...47,050,751
|
|
G |
CYP7A1 |
cytochrome P450 family 7 subfamily A member 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CYP7A1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
|
|
G |
CYP7B1 |
cytochrome P450 family 7 subfamily B member 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CYP7B1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:64,586,575...64,798,737
Ensembl chr 8:64,587,763...64,798,737
|
|
G |
CYP8B1 |
cytochrome P450 family 8 subfamily B member 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CYP8B1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:42,872,192...42,875,879
Ensembl chr 3:42,856,005...42,875,898
|
|
G |
DAB1 |
DAB adaptor protein 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of DAB1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:56,994,778...58,546,726
Ensembl chr 1:56,994,778...58,546,734
|
|
G |
DACH2 |
dachshund family transcription factor 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of DACH2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr X:86,148,451...86,832,602
Ensembl chr X:86,148,451...86,832,604
|
|
G |
DAO |
D-amino acid oxidase |
decreases expression |
EXP |
methyleugenol results in decreased expression of DAO mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:108,880,092...108,901,043
Ensembl chr12:108,858,932...108,901,043
|
|
G |
DBH-AS1 |
DBH antisense RNA 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of DBH-AS1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:133,654,587...133,657,408
Ensembl chr 9:133,654,586...133,657,313
|
|
G |
DBNDD1 |
dysbindin domain containing 1 |
increases expression |
EXP |
methyleugenol results in increased expression of DBNDD1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:90,004,871...90,019,890
Ensembl chr16:90,004,871...90,019,890
|
|
G |
DCAF11 |
DDB1 and CUL4 associated factor 11 |
decreases expression |
EXP |
methyleugenol results in decreased expression of DCAF11 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:24,114,777...24,125,242
Ensembl chr14:24,114,195...24,125,242
|
|
G |
DCDC1 |
doublecortin domain containing 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of DCDC1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:30,863,603...31,369,739
Ensembl chr11:30,830,369...31,369,810
|
|
G |
DCHS2 |
dachsous cadherin-related 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of DCHS2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:154,231,742...154,491,799
Ensembl chr 4:154,231,742...154,491,799
|
|
G |
DCXR |
dicarbonyl and L-xylulose reductase |
decreases expression |
EXP |
methyleugenol results in decreased expression of DCXR mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:82,035,858...82,037,697
Ensembl chr17:82,035,136...82,037,709
|
|
G |
DDC |
dopa decarboxylase |
decreases expression |
EXP |
methyleugenol results in decreased expression of DDC mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:50,458,442...50,565,405
Ensembl chr 7:50,458,436...50,565,405
|
|
G |
DDR2 |
discoidin domain receptor tyrosine kinase 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of DDR2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:162,630,863...162,787,405
Ensembl chr 1:162,631,373...162,787,405
|
|
G |
DDT |
D-dopachrome tautomerase |
decreases expression |
EXP |
methyleugenol results in decreased expression of DDT mRNA |
CTD |
PMID:32234424 |
|
NCBI chr22:23,971,370...23,980,504
Ensembl chr22:23,970,542...23,980,525
|
|
G |
DEFB1 |
defensin beta 1 |
increases expression |
EXP |
methyleugenol results in increased expression of DEFB1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:6,870,592...6,877,936
Ensembl chr 8:6,870,592...6,877,936
|
|
G |
DENND1A |
DENN domain containing 1A |
decreases expression |
EXP |
methyleugenol results in decreased expression of DENND1A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:123,379,658...123,930,126
Ensembl chr 9:123,379,654...123,930,152
|
|
G |
DGAT1 |
diacylglycerol O-acyltransferase 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of DGAT1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:144,314,584...144,326,852
Ensembl chr 8:144,314,584...144,326,910
|
|
G |
DGAT2 |
diacylglycerol O-acyltransferase 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of DGAT2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:75,768,778...75,801,534
Ensembl chr11:75,759,512...75,801,535
|
|
G |
DHRS2 |
dehydrogenase/reductase 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of DHRS2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:23,630,115...23,645,639
Ensembl chr14:23,630,115...23,645,639
|
|
G |
DHRS9 |
dehydrogenase/reductase 9 |
increases expression |
EXP |
methyleugenol results in increased expression of DHRS9 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:169,067,077...169,096,167
Ensembl chr 2:169,064,789...169,096,167
|
|
G |
DHRSX |
dehydrogenase/reductase X-linked |
decreases expression |
EXP |
methyleugenol results in decreased expression of DHRSX mRNA |
CTD |
PMID:32234424 |
|
NCBI chr X:2,219,506...2,500,976 NCBI chr Y:2,219,506...2,500,976
Ensembl chr X:2,219,506...2,502,805 Ensembl chr Y:2,219,506...2,502,805
|
|
G |
DHTKD1 |
dehydrogenase E1 and transketolase domain containing 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of DHTKD1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:12,068,954...12,123,221
Ensembl chr10:12,068,954...12,123,221
|
|
G |
DIAPH2 |
diaphanous related formin 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of DIAPH2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr X:96,684,842...97,604,997
Ensembl chr X:96,684,712...97,604,997
|
|
G |
DIO1 |
iodothyronine deiodinase 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of DIO1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:53,894,187...53,911,086
Ensembl chr 1:53,891,239...53,911,086
|
|
G |
DIP2C |
disco interacting protein 2 homolog C |
decreases expression |
EXP |
methyleugenol results in decreased expression of DIP2C mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:274,201...689,668
Ensembl chr10:274,201...689,668
|
|
G |
DIRAS3 |
DIRAS family GTPase 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of DIRAS3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:68,045,962...68,050,627
Ensembl chr 1:68,045,886...68,051,717
|
|
G |
DISC1 |
DISC1 scaffold protein |
decreases expression |
EXP |
methyleugenol results in decreased expression of DISC1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:231,626,790...232,041,272
Ensembl chr 1:231,626,790...232,041,272
|
|
G |
DLG2 |
discs large MAGUK scaffold protein 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of DLG2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:83,455,012...85,628,373
Ensembl chr11:83,455,012...85,628,335
|
|
G |
DMGDH |
dimethylglycine dehydrogenase |
decreases expression |
EXP |
methyleugenol results in decreased expression of DMGDH mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:78,997,564...79,069,674
Ensembl chr 5:78,997,564...79,236,038
|
|
G |
DNAH1 |
dynein axonemal heavy chain 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of DNAH1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:52,310,920...52,400,492
Ensembl chr 3:52,316,319...52,400,492
|
|
G |
DNAH11 |
dynein axonemal heavy chain 11 |
decreases expression |
EXP |
methyleugenol results in decreased expression of DNAH11 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:21,543,039...21,901,839
Ensembl chr 7:21,543,039...21,901,839
|
|
G |
DNAH12 |
dynein axonemal heavy chain 12 |
decreases expression |
EXP |
methyleugenol results in decreased expression of DNAH12 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:57,293,700...57,556,034
Ensembl chr 3:57,293,699...57,544,344
|
|
G |
DNAH5 |
dynein axonemal heavy chain 5 |
decreases expression |
EXP |
methyleugenol results in decreased expression of DNAH5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:13,690,328...14,011,818
Ensembl chr 5:13,690,328...14,011,818
|
|
G |
DNAH6 |
dynein axonemal heavy chain 6 |
decreases expression |
EXP |
methyleugenol results in decreased expression of DNAH6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:84,459,572...84,819,589
Ensembl chr 2:84,516,455...84,819,589
|
|
G |
DNASE2 |
deoxyribonuclease 2, lysosomal |
increases expression |
ISO |
methyleugenol results in increased expression of DNASE2A mRNA |
CTD |
PMID:15618236 |
|
NCBI chr19:12,875,209...12,881,449
Ensembl chr19:12,875,209...12,881,595
|
|
G |
DOCK1 |
dedicator of cytokinesis 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of DOCK1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:126,905,428...127,452,516
Ensembl chr10:126,905,409...127,452,517
|
|
G |
DOCK8 |
dedicator of cytokinesis 8 |
decreases expression |
EXP |
methyleugenol results in decreased expression of DOCK8 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:211,257...465,255
Ensembl chr 9:214,854...465,259
|
|
G |
DPF3 |
double PHD fingers 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of DPF3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:72,609,034...72,894,101
Ensembl chr14:72,609,034...72,894,101
|
|
G |
DPYD |
dihydropyrimidine dehydrogenase |
decreases expression |
EXP |
methyleugenol results in decreased expression of DPYD mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:97,077,743...97,921,059
Ensembl chr 1:97,077,743...97,995,000
|
|
G |
DPYS |
dihydropyrimidinase |
decreases expression |
EXP |
methyleugenol results in decreased expression of DPYS mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:104,379,431...104,467,055
Ensembl chr 8:104,330,324...104,467,055
|
|
G |
DRAXIN |
dorsal inhibitory axon guidance protein |
increases expression |
EXP |
methyleugenol results in increased expression of DRAXIN mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:11,686,635...11,725,857
Ensembl chr 1:11,691,710...11,725,857
|
|
G |
DRGX |
dorsal root ganglia homeobox |
decreases expression |
EXP |
methyleugenol results in decreased expression of DRGX mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:49,364,066...49,396,089
Ensembl chr10:49,364,066...49,396,089
|
|
G |
DSC2 |
desmocollin 2 |
increases expression |
EXP |
methyleugenol results in increased expression of DSC2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr18:31,058,840...31,102,421
Ensembl chr18:31,058,545...31,102,600
|
|
G |
DUSP15 |
dual specificity phosphatase 15 |
increases expression |
EXP |
methyleugenol results in increased expression of DUSP15 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr20:31,845,593...31,870,664
Ensembl chr20:31,847,637...31,870,664
|
|
G |
DUSP9 |
dual specificity phosphatase 9 |
decreases expression |
EXP |
methyleugenol results in decreased expression of DUSP9 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr X:153,642,441...153,651,326
Ensembl chr X:153,642,492...153,651,326
|
|
G |
DYNC2H1 |
dynein cytoplasmic 2 heavy chain 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of DYNC2H1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:103,109,426...103,479,863
Ensembl chr11:103,109,410...103,479,863
|
|
G |
EBF1 |
EBF transcription factor 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of EBF1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:158,695,920...159,099,916
Ensembl chr 5:158,695,920...159,099,916
|
|
G |
ECM2 |
extracellular matrix protein 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ECM2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:92,493,547...92,559,106
Ensembl chr 9:92,493,554...92,536,655
|
|
G |
EDIL3 |
EGF like repeats and discoidin domains 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of EDIL3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:83,940,554...84,384,880
Ensembl chr 5:83,940,554...84,384,880
|
|
G |
EEF1A2 |
eukaryotic translation elongation factor 1 alpha 2 |
increases expression |
EXP |
methyleugenol results in increased expression of EEF1A2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr20:63,488,014...63,499,083
Ensembl chr20:63,488,013...63,499,239
|
|
G |
EFCAB11 |
EF-hand calcium binding domain 11 |
decreases expression |
EXP |
methyleugenol results in decreased expression of EFCAB11 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:89,794,669...89,954,777
Ensembl chr14:89,794,669...89,954,777
|
|
G |
EFCAB6 |
EF-hand calcium binding domain 6 |
decreases expression |
EXP |
methyleugenol results in decreased expression of EFCAB6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr22:43,528,778...43,812,305
Ensembl chr22:43,528,744...43,812,337
|
|
G |
EGFR |
epidermal growth factor receptor |
decreases expression |
ISO |
methyleugenol results in decreased expression of EGFR protein |
CTD |
PMID:15618236 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
EGR1 |
early growth response 1 |
increases expression |
ISO |
methyleugenol results in increased expression of EGR1 mRNA |
CTD |
PMID:15618236 |
|
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
|
|
G |
EHBP1L1 |
EH domain binding protein 1 like 1 |
increases expression |
EXP |
methyleugenol results in increased expression of EHBP1L1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:65,576,053...65,592,650
Ensembl chr11:65,576,046...65,592,650
|
|
G |
EHHADH |
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase |
decreases expression |
EXP |
methyleugenol results in decreased expression of EHHADH mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:185,190,624...185,254,049
Ensembl chr 3:185,190,624...185,281,990
|
|
G |
ELAPOR1 |
endosome-lysosome associated apoptosis and autophagy regulator 1 |
increases expression |
EXP |
methyleugenol results in increased expression of ELAPOR1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:109,114,115...109,206,781
Ensembl chr 1:109,113,679...109,206,781
|
|
G |
ELMO1 |
engulfment and cell motility 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ELMO1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:36,852,906...37,449,326
Ensembl chr 7:36,852,906...37,449,223
|
|
G |
ELP4 |
elongator acetyltransferase complex subunit 4 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ELP4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:31,509,767...31,790,324
Ensembl chr11:31,509,755...31,790,324
|
|
G |
EML6 |
EMAP like 6 |
decreases expression |
EXP |
methyleugenol results in decreased expression of EML6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:54,723,552...54,972,025
Ensembl chr 2:54,723,499...54,972,025
|
|
G |
ENOX1 |
ecto-NOX disulfide-thiol exchanger 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ENOX1 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr13:43,213,130...43,786,972
Ensembl chr13:43,213,130...43,786,972
|
|
G |
ENPP3 |
ectonucleotide pyrophosphatase/phosphodiesterase 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ENPP3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:131,637,302...131,747,410
Ensembl chr 6:131,628,442...131,747,418
|
|
G |
ENPP6 |
ectonucleotide pyrophosphatase/phosphodiesterase 6 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ENPP6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:184,088,706...184,217,873
Ensembl chr 4:184,088,706...184,221,230
|
|
G |
ENTPD8 |
ectonucleoside triphosphate diphosphohydrolase 8 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ENTPD8 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:137,434,364...137,441,357
Ensembl chr 9:137,434,364...137,441,816
|
|
G |
EPHX2 |
epoxide hydrolase 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of EPHX2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:27,491,143...27,548,626
Ensembl chr 8:27,490,781...27,545,564
|
|
G |
EPM2A |
EPM2A glucan phosphatase, laforin |
decreases expression |
EXP |
methyleugenol results in decreased expression of EPM2A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:145,383,353...145,736,023
Ensembl chr 6:145,382,535...145,736,023
|
|
G |
EPS8L3 |
EPS8 signaling adaptor L3 |
increases expression |
EXP |
methyleugenol results in increased expression of EPS8L3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:109,750,080...109,763,923
Ensembl chr 1:109,750,080...109,764,027
|
|
G |
ERBB4 |
erb-b2 receptor tyrosine kinase 4 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ERBB4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:211,375,717...212,538,802
Ensembl chr 2:211,375,717...212,538,841
|
|
G |
EREG |
epiregulin |
increases expression |
EXP |
methyleugenol results in increased expression of EREG mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:74,365,145...74,388,749
Ensembl chr 4:74,365,145...74,388,749
|
|
G |
ERICH4 |
glutamate rich 4 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ERICH4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:41,443,156...41,444,765
Ensembl chr19:41,443,156...41,444,765
|
|
G |
ERP27 |
endoplasmic reticulum protein 27 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ERP27 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:14,914,039...14,938,537
Ensembl chr12:14,914,039...14,938,537
|
|
G |
ESAM |
endothelial cell adhesion molecule |
increases expression |
EXP |
methyleugenol results in increased expression of ESAM mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:124,753,126...124,762,290
Ensembl chr11:124,752,583...124,762,290
|
|
G |
ESCO1 |
establishment of sister chromatid cohesion N-acetyltransferase 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ESCO1 mRNA |
CTD |
PMID:26011634 |
|
NCBI chr18:21,529,284...21,600,704
Ensembl chr18:21,529,281...21,600,884
|
|
G |
ESPL1 |
extra spindle pole bodies like 1, separase |
decreases expression |
EXP |
methyleugenol results in decreased expression of ESPL1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:53,268,299...53,293,638
Ensembl chr12:53,268,299...53,293,638
|
|
G |
ESPN |
espin |
decreases expression |
EXP |
methyleugenol results in decreased expression of ESPN mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:6,424,776...6,461,370
Ensembl chr 1:6,424,776...6,461,367
|
|
G |
ESRRG |
estrogen related receptor gamma |
decreases expression |
EXP |
methyleugenol results in decreased expression of ESRRG mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:216,503,246...217,137,702
Ensembl chr 1:216,503,246...217,137,755
|
|
G |
ETNK2 |
ethanolamine kinase 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ETNK2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:204,131,062...204,152,044
Ensembl chr 1:204,131,062...204,152,044
|
|
G |
EVA1B |
eva-1 homolog B |
increases expression |
EXP |
methyleugenol results in increased expression of EVA1B mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:36,322,030...36,324,154
Ensembl chr 1:36,322,030...36,324,154
|
|
G |
EXOC3L4 |
exocyst complex component 3 like 4 |
decreases expression |
EXP |
methyleugenol results in decreased expression of EXOC3L4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:103,094,174...103,110,559
Ensembl chr14:103,094,725...103,110,559
|
|
G |
EXOC4 |
exocyst complex component 4 |
decreases expression |
EXP |
methyleugenol results in decreased expression of EXOC4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:133,253,078...134,100,951
Ensembl chr 7:133,253,072...134,067,137
|
|
G |
EYA2 |
EYA transcriptional coactivator and phosphatase 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of EYA2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr20:46,894,843...47,188,844
Ensembl chr20:46,894,624...47,188,844
|
|
G |
EYA4 |
EYA transcriptional coactivator and phosphatase 4 |
decreases expression |
EXP |
methyleugenol results in decreased expression of EYA4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:133,240,593...133,532,128
Ensembl chr 6:133,240,514...133,532,128
|
|
G |
F11 |
coagulation factor XI |
decreases expression |
EXP |
methyleugenol results in decreased expression of F11 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:186,266,189...186,289,681
Ensembl chr 4:186,266,189...186,289,681
|
|
G |
F12 |
coagulation factor XII |
decreases expression |
EXP |
methyleugenol results in decreased expression of F12 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:177,402,141...177,409,564
Ensembl chr 5:177,402,133...177,416,583
|
|
G |
F2RL2 |
coagulation factor II thrombin receptor like 2 |
increases expression |
EXP |
methyleugenol results in increased expression of F2RL2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:76,615,482...76,623,403
Ensembl chr 5:76,615,482...76,623,413
|
|
G |
F7 |
coagulation factor VII |
decreases expression |
EXP |
methyleugenol results in decreased expression of F7 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:113,105,788...113,120,685
Ensembl chr13:113,105,788...113,120,685
|
|
G |
F9 |
coagulation factor IX |
decreases expression |
EXP |
methyleugenol results in decreased expression of F9 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr X:139,530,739...139,563,459
Ensembl chr X:139,530,739...139,563,459
|
|
G |
FABP1 |
fatty acid binding protein 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of FABP1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:88,122,982...88,128,062
Ensembl chr 2:88,122,982...88,128,062
|
|
G |
FAM151A |
family with sequence similarity 151 member A |
decreases expression |
EXP |
methyleugenol results in decreased expression of FAM151A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:54,609,181...54,623,525
Ensembl chr 1:54,609,181...54,623,556
|
|
G |
FAM167A |
family with sequence similarity 167 member A |
increases expression |
EXP |
methyleugenol results in increased expression of FAM167A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:11,421,476...11,475,908
Ensembl chr 8:11,421,476...11,475,908
|
|
G |
FAM171A2 |
family with sequence similarity 171 member A2 |
increases expression |
EXP |
methyleugenol results in increased expression of FAM171A2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:44,353,215...44,363,853
Ensembl chr17:44,353,215...44,363,853
|
|
G |
FAM72B |
family with sequence similarity 72 member B |
decreases expression |
EXP |
methyleugenol results in decreased expression of FAM72B mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:121,167,646...121,184,340
Ensembl chr 1:121,167,646...121,185,539
|
|
G |
FAM78B |
family with sequence similarity 78 member B |
decreases expression |
EXP |
methyleugenol results in decreased expression of FAM78B mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:166,055,918...166,167,001
Ensembl chr 1:166,057,426...166,167,001
|
|
G |
FAM83D |
family with sequence similarity 83 member D |
decreases expression |
EXP |
methyleugenol results in decreased expression of FAM83D mRNA |
CTD |
PMID:32234424 |
|
NCBI chr20:38,926,417...38,953,106
Ensembl chr20:38,926,312...38,953,106
|
|
G |
FANK1 |
fibronectin type III and ankyrin repeat domains 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of FANK1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:125,896,564...126,009,592
Ensembl chr10:125,896,564...126,009,592
|
|
G |
FAR1 |
fatty acyl-CoA reductase 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of FAR1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:13,668,668...13,732,346
Ensembl chr11:13,668,659...13,732,346
|
|
G |
FARS2 |
phenylalanyl-tRNA synthetase 2, mitochondrial |
decreases expression |
EXP |
methyleugenol results in decreased expression of FARS2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:5,249,934...5,771,583
Ensembl chr 6:5,261,044...5,829,192
|
|
G |
FASN |
fatty acid synthase |
decreases expression |
EXP |
methyleugenol results in decreased expression of FASN mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294
|
|
G |
FAT3 |
FAT atypical cadherin 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of FAT3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:92,224,818...92,896,473
Ensembl chr11:92,224,818...92,896,473
|
|
G |
FBLIM1 |
filamin binding LIM protein 1 |
increases expression |
EXP |
methyleugenol results in increased expression of FBLIM1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:15,756,638...15,786,589
Ensembl chr 1:15,756,607...15,786,594
|
|
G |
FBP1 |
fructose-bisphosphatase 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of FBP1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:94,603,133...94,640,263
Ensembl chr 9:94,603,133...94,640,249
|
|
G |
FBXL17 |
F-box and leucine rich repeat protein 17 |
decreases expression |
EXP |
methyleugenol results in decreased expression of FBXL17 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:107,859,035...108,382,098
Ensembl chr 5:107,859,035...108,382,098
|
|
G |
FBXO15 |
F-box protein 15 |
decreases expression |
EXP |
methyleugenol results in decreased expression of FBXO15 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr18:74,073,368...74,147,834
Ensembl chr18:74,073,353...74,147,843
|
|
G |
FBXO43 |
F-box protein 43 |
decreases expression |
EXP |
methyleugenol results in decreased expression of FBXO43 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:100,133,351...100,150,569
Ensembl chr 8:100,133,351...100,145,817
|
|
G |
FER |
FER tyrosine kinase |
decreases expression |
EXP |
methyleugenol results in decreased expression of FER mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:108,747,897...109,196,841
Ensembl chr 5:108,747,841...109,196,841
|
|
G |
FER1L6 |
fer-1 like family member 6 |
decreases expression |
EXP |
methyleugenol results in decreased expression of FER1L6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:123,851,987...124,120,061
Ensembl chr 8:123,851,987...124,120,061
|
|
G |
FETUB |
fetuin B |
decreases expression |
EXP |
methyleugenol results in decreased expression of FETUB mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:186,635,969...186,653,141
Ensembl chr 3:186,635,969...186,653,141
|
|
G |
FGA |
fibrinogen alpha chain |
decreases expression |
EXP |
methyleugenol results in decreased expression of FGA mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:154,583,126...154,590,742
Ensembl chr 4:154,583,126...154,590,742
|
|
G |
FGB |
fibrinogen beta chain |
decreases expression |
EXP |
methyleugenol results in decreased expression of FGB mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:154,562,980...154,572,807
Ensembl chr 4:154,563,011...154,572,807
|
|
G |
FGD5 |
FYVE, RhoGEF and PH domain containing 5 |
decreases expression |
EXP |
methyleugenol results in decreased expression of FGD5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:14,810,688...14,934,571
Ensembl chr 3:14,810,853...14,934,571
|
|
G |
FGF12 |
fibroblast growth factor 12 |
decreases expression |
EXP |
methyleugenol results in decreased expression of FGF12 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:192,139,390...192,727,541
Ensembl chr 3:192,139,390...192,767,764
|
|
G |
FGF13 |
fibroblast growth factor 13 |
decreases expression |
EXP |
methyleugenol results in decreased expression of FGF13 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr X:138,614,727...139,205,023
Ensembl chr X:138,614,727...139,222,777
|
|
G |
FGF14 |
fibroblast growth factor 14 |
decreases expression |
EXP |
methyleugenol results in decreased expression of FGF14 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:101,710,804...102,402,443
Ensembl chr13:101,710,804...102,402,457
|
|
G |
FGFR2 |
fibroblast growth factor receptor 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of FGFR2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:121,478,330...121,598,458
Ensembl chr10:121,478,332...121,598,458
|
|
G |
FGGY |
FGGY carbohydrate kinase domain containing |
decreases expression |
EXP |
methyleugenol results in decreased expression of FGGY mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:59,296,378...59,762,730
Ensembl chr 1:59,296,638...59,810,647
|
|
G |
FGL2 |
fibrinogen like 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of FGL2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:77,193,369...77,199,819
Ensembl chr 7:77,193,369...77,199,848
|
|
G |
FHIT |
fragile histidine triad diadenosine triphosphatase |
decreases expression |
ISO EXP |
methyleugenol results in decreased expression of FHIT mRNA; methyleugenol results in decreased expression of FHIT protein |
CTD |
PMID:15618236 PMID:32234424 PMID:35690182 |
|
NCBI chr 3:59,747,277...61,251,452
Ensembl chr 3:59,747,277...61,251,459
|
|
G |
FHOD3 |
formin homology 2 domain containing 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of FHOD3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr18:36,297,713...36,780,220
Ensembl chr18:36,297,713...36,780,220
|
|
G |
FILIP1 |
filamin A interacting protein 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of FILIP1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:75,291,859...75,493,800
Ensembl chr 6:75,291,859...75,493,800
|
|
G |
FILIP1L |
filamin A interacting protein 1 like |
increases expression |
EXP |
methyleugenol results in increased expression of FILIP1L mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:99,828,811...100,114,501
Ensembl chr 3:99,828,811...100,114,513
|
|
G |
FITM1 |
fat storage inducing transmembrane protein 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of FITM1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:24,130,659...24,132,847
Ensembl chr14:24,130,659...24,132,849
|
|
G |
FLRT2 |
fibronectin leucine rich transmembrane protein 2 |
increases expression |
EXP |
methyleugenol results in increased expression of FLRT2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:85,530,144...85,654,428
Ensembl chr14:85,530,144...85,654,428
|
|
G |
FMO1 |
flavin containing dimethylaniline monoxygenase 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of FMO1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:171,248,494...171,285,978
Ensembl chr 1:171,248,471...171,285,978
|
|
G |
FMO5 |
flavin containing dimethylaniline monoxygenase 5 |
decreases expression |
EXP |
methyleugenol results in decreased expression of FMO5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:147,184,305...147,227,284
Ensembl chr 1:147,175,351...147,243,050
|
|
G |
FOLH1B |
folate hydrolase 1B (pseudogene) |
decreases expression |
EXP |
methyleugenol results in decreased expression of FOLH1B mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:89,659,268...89,698,718
Ensembl chr11:89,639,237...89,698,599 Ensembl chr11:89,639,237...89,698,599
|
|
G |
FOSL1 |
FOS like 1, AP-1 transcription factor subunit |
increases expression |
EXP |
methyleugenol results in increased expression of FOSL1 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr11:65,892,049...65,900,545
Ensembl chr11:65,892,049...65,900,573
|
|
G |
FOXA3 |
forkhead box A3 |
increases expression |
EXP |
methyleugenol results in increased expression of FOXA3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:45,864,326...45,873,797
Ensembl chr19:45,863,989...45,873,797
|
|
G |
FRAS1 |
Fraser extracellular matrix complex subunit 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of FRAS1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:78,057,323...78,544,269
Ensembl chr 4:78,057,323...78,544,269
|
|
G |
FRMPD2 |
FERM and PDZ domain containing 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of FRMPD2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:48,156,559...48,274,895
Ensembl chr10:48,153,088...48,274,696
|
|
G |
FST |
follistatin |
increases expression |
EXP |
methyleugenol results in increased expression of FST mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:53,480,629...53,487,134
Ensembl chr 5:53,480,626...53,487,134
|
|
G |
FTO |
FTO alpha-ketoglutarate dependent dioxygenase |
decreases expression |
EXP |
methyleugenol results in decreased expression of FTO mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:53,703,963...54,121,941
Ensembl chr16:53,701,692...54,158,512
|
|
G |
FUOM |
fucose mutarotase |
decreases expression |
EXP |
methyleugenol results in decreased expression of FUOM mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:133,352,773...133,358,019
Ensembl chr10:133,353,952...133,358,025
|
|
G |
FUT6 |
fucosyltransferase 6 |
decreases expression |
EXP |
methyleugenol results in decreased expression of FUT6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:5,830,408...5,839,702
Ensembl chr19:5,830,408...5,839,722
|
|
G |
FXYD5 |
FXYD domain containing ion transport regulator 5 |
increases expression |
EXP |
methyleugenol results in increased expression of FXYD5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:35,154,735...35,169,881
Ensembl chr19:35,154,730...35,171,791
|
|
G |
FYB2 |
FYN binding protein 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of FYB2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:56,718,789...56,826,914
Ensembl chr 1:56,718,789...56,819,696
|
|
G |
FYN |
FYN proto-oncogene, Src family tyrosine kinase |
decreases expression |
EXP |
methyleugenol results in decreased expression of FYN mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:111,660,332...111,873,452
Ensembl chr 6:111,660,332...111,873,452
|
|
G |
G0S2 |
G0/G1 switch 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of G0S2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:209,675,412...209,676,390
Ensembl chr 1:209,675,412...209,676,390
|
|
G |
G6PC1 |
glucose-6-phosphatase catalytic subunit 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of G6PC1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:42,900,799...42,914,438
Ensembl chr17:42,900,797...42,914,438
|
|
G |
GAD1 |
glutamate decarboxylase 1 |
increases expression |
EXP |
methyleugenol results in increased expression of GAD1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:170,813,210...170,861,151
Ensembl chr 2:170,813,213...170,861,151
|
|
G |
GADD45B |
growth arrest and DNA damage inducible beta |
increases expression |
ISO |
methyleugenol results in increased expression of GADD45B mRNA |
CTD |
PMID:15618236 |
|
NCBI chr19:2,476,127...2,478,257
Ensembl chr19:2,476,122...2,478,805
|
|
G |
GALNT13 |
polypeptide N-acetylgalactosaminyltransferase 13 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GALNT13 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:153,068,293...154,456,574
Ensembl chr 2:153,871,922...154,453,979 Ensembl chr 2:153,871,922...154,453,979
|
|
G |
GALNT16 |
polypeptide N-acetylgalactosaminyltransferase 16 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GALNT16 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:69,259,631...69,386,337
Ensembl chr14:69,259,277...69,357,033
|
|
G |
GALNTL6 |
polypeptide N-acetylgalactosaminyltransferase like 6 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GALNTL6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:171,813,404...173,041,559
Ensembl chr 4:171,812,254...173,041,559
|
|
G |
GAPDHP23 |
glyceraldehyde 3 phosphate dehydrogenase pseudogene 23 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GAPDHP23 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:119,461,835...119,463,092
Ensembl chr 1:119,462,029...119,463,021
|
|
G |
GAS1 |
growth arrest specific 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GAS1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:86,944,362...86,947,506
Ensembl chr 9:86,944,362...86,947,506
|
|
G |
GATM |
glycine amidinotransferase |
decreases expression |
EXP |
methyleugenol results in decreased expression of GATM mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:45,361,124...45,402,227
Ensembl chr15:45,361,124...45,402,327
|
|
G |
GBA3 |
glucosylceramidase beta 3 (gene/pseudogene) |
decreases expression |
EXP |
methyleugenol results in decreased expression of GBA3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:22,692,937...22,819,569
Ensembl chr 4:22,692,914...22,819,575
|
|
G |
GBP7 |
guanylate binding protein 7 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GBP7 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:89,131,742...89,176,003
Ensembl chr 1:89,131,742...89,176,009
|
|
G |
GC |
GC vitamin D binding protein |
decreases expression |
EXP |
methyleugenol results in decreased expression of GC mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:71,741,693...71,805,520
Ensembl chr 4:71,741,696...71,804,041
|
|
G |
GCDH |
glutaryl-CoA dehydrogenase |
decreases expression |
EXP |
methyleugenol results in decreased expression of GCDH mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:12,891,129...12,899,999
Ensembl chr19:12,891,128...12,915,126
|
|
G |
GCGR |
glucagon receptor |
decreases expression |
EXP |
methyleugenol results in decreased expression of GCGR mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:81,804,150...81,814,008
Ensembl chr17:81,804,132...81,814,008
|
|
G |
GCHFR |
GTP cyclohydrolase I feedback regulator |
decreases expression |
EXP |
methyleugenol results in decreased expression of GCHFR mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:40,764,068...40,767,708
Ensembl chr15:40,764,068...40,767,708
|
|
G |
GCNT3 |
glucosaminyl (N-acetyl) transferase 3, mucin type |
increases expression |
EXP |
methyleugenol results in increased expression of GCNT3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:59,611,783...59,622,723
Ensembl chr15:59,594,875...59,640,239
|
|
G |
GDF11 |
growth differentiation factor 11 |
increases expression |
EXP |
methyleugenol results in increased expression of GDF11 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:55,743,122...55,757,264
Ensembl chr12:55,743,122...55,757,264
|
|
G |
GDF15 |
growth differentiation factor 15 |
increases expression |
EXP |
methyleugenol results in increased expression of GDF15 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr19:18,386,158...18,389,176
Ensembl chr19:18,374,731...18,389,176
|
|
G |
GDNF |
glial cell derived neurotrophic factor |
increases expression |
EXP |
methyleugenol results in increased expression of GDNF mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:37,812,677...37,840,041
Ensembl chr 5:37,812,677...37,840,041
|
|
G |
GEM |
GTP binding protein overexpressed in skeletal muscle |
increases expression |
EXP |
methyleugenol results in increased expression of GEM mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:94,249,253...94,262,319
Ensembl chr 8:94,249,253...94,262,350
|
|
G |
GFPT2 |
glutamine-fructose-6-phosphate transaminase 2 |
increases expression |
EXP |
methyleugenol results in increased expression of GFPT2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:180,300,698...180,353,336
Ensembl chr 5:180,300,698...180,353,336
|
|
G |
GFRA1 |
GDNF family receptor alpha 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GFRA1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:116,056,925...116,274,705
Ensembl chr10:116,056,925...116,276,803
|
|
G |
GHR |
growth hormone receptor |
decreases expression |
EXP |
methyleugenol results in decreased expression of GHR mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:42,423,439...42,721,878
Ensembl chr 5:42,423,439...42,721,878
|
|
G |
GIPC2 |
GIPC PDZ domain containing family member 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GIPC2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:78,044,970...78,138,444
Ensembl chr 1:77,979,542...78,138,444
|
|
G |
GJA3 |
gap junction protein alpha 3 |
increases expression |
EXP |
methyleugenol results in increased expression of GJA3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:20,138,255...20,161,565
Ensembl chr13:20,138,255...20,161,052
|
|
G |
GLA |
galactosidase alpha |
increases expression |
EXP |
methyleugenol results in increased expression of GLA mRNA |
CTD |
PMID:32234424 |
|
NCBI chr X:101,397,803...101,407,925
Ensembl chr X:101,393,273...101,408,012
|
|
G |
GLDC |
glycine decarboxylase |
decreases expression |
EXP |
methyleugenol results in decreased expression of GLDC mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:6,532,467...6,645,729
Ensembl chr 9:6,532,467...6,645,729
|
|
G |
GLIPR1 |
GLI pathogenesis related 1 |
increases expression |
EXP |
methyleugenol results in increased expression of GLIPR1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:75,480,755...75,503,863
Ensembl chr12:75,480,753...75,503,863
|
|
G |
GLIPR2 |
GLI pathogenesis related 2 |
increases expression |
EXP |
methyleugenol results in increased expression of GLIPR2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:36,136,536...36,163,913
Ensembl chr 9:36,136,536...36,163,913
|
|
G |
GLRA3 |
glycine receptor alpha 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GLRA3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:174,636,920...174,829,247
Ensembl chr 4:174,636,920...174,829,247
|
|
G |
GLS2 |
glutaminase 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GLS2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:56,470,952...56,488,161
Ensembl chr12:56,470,944...56,488,414
|
|
G |
GLTPD2 |
glycolipid transfer protein domain containing 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GLTPD2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:4,788,964...4,790,589
Ensembl chr17:4,788,964...4,790,589
|
|
G |
GLUD1 |
glutamate dehydrogenase 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GLUD1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:87,050,202...87,094,843
Ensembl chr10:87,050,202...87,094,843
|
|
G |
GLUL |
glutamate-ammonia ligase |
decreases expression |
EXP |
methyleugenol results in decreased expression of GLUL mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:182,378,098...182,391,790
Ensembl chr 1:182,378,098...182,392,206
|
|
G |
GLYAT |
glycine-N-acyltransferase |
decreases expression |
EXP |
methyleugenol results in decreased expression of GLYAT mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:58,708,757...58,731,943
Ensembl chr11:58,640,426...58,731,974
|
|
G |
GLYATL1 |
glycine-N-acyltransferase like 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GLYATL1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:58,905,481...58,956,406
Ensembl chr11:58,905,398...59,043,527
|
|
G |
GLYCTK |
glycerate kinase |
decreases expression |
EXP |
methyleugenol results in decreased expression of GLYCTK mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:52,287,828...52,295,257
Ensembl chr 3:52,287,089...52,295,257
|
|
G |
GMDS |
GDP-mannose 4,6-dehydratase |
decreases expression |
EXP |
methyleugenol results in decreased expression of GMDS mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:1,623,806...2,245,605
Ensembl chr 6:1,623,806...2,245,605
|
|
G |
GNG12-AS1 |
GNG12, DIRAS3 and WLS antisense RNA 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GNG12-AS1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:67,832,288...68,202,987
Ensembl chr 1:67,832,193...68,202,987
|
|
G |
GNG7 |
G protein subunit gamma 7 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GNG7 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:2,511,219...2,702,694
Ensembl chr19:2,511,219...2,702,694
|
|
G |
GNMT |
glycine N-methyltransferase |
decreases expression |
EXP |
methyleugenol results in decreased expression of GNMT mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr 6:42,960,754...42,963,880
Ensembl chr 6:42,960,754...42,963,880
|
|
G |
GOLGA8S |
golgin A8 family member S |
increases expression |
EXP |
methyleugenol results in increased expression of GOLGA8S mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:23,354,748...23,368,489
Ensembl chr15:23,354,748...23,368,341
|
|
G |
GPAM |
glycerol-3-phosphate acyltransferase, mitochondrial |
decreases expression |
EXP |
methyleugenol results in decreased expression of GPAM mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:112,149,865...112,227,677
Ensembl chr10:112,149,865...112,215,377
|
|
G |
GPC2 |
glypican 2 |
increases expression |
EXP |
methyleugenol results in increased expression of GPC2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:100,169,606...100,177,381
Ensembl chr 7:100,169,606...100,177,381
|
|
G |
GPC5 |
glypican 5 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GPC5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:91,398,621...92,867,237
Ensembl chr13:91,398,621...92,873,682
|
|
G |
GPC6 |
glypican 6 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GPC6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:93,216,529...94,408,020
Ensembl chr13:93,226,807...94,408,020
|
|
G |
GPD1 |
glycerol-3-phosphate dehydrogenase 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GPD1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:50,104,008...50,111,313
Ensembl chr12:50,103,982...50,111,313
|
|
G |
GPHN |
gephyrin |
decreases expression |
EXP |
methyleugenol results in decreased expression of GPHN mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:66,508,147...67,735,355
Ensembl chr14:66,507,407...67,181,803
|
|
G |
GPM6A |
glycoprotein M6A |
decreases expression |
EXP |
methyleugenol results in decreased expression of GPM6A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:175,632,937...176,002,393
Ensembl chr 4:175,632,934...176,002,664
|
|
G |
GPR153 |
G protein-coupled receptor 153 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GPR153 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:6,247,353...6,261,098
Ensembl chr 1:6,247,353...6,261,098
|
|
G |
GPR160 |
G protein-coupled receptor 160 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GPR160 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:170,037,995...170,085,392
Ensembl chr 3:170,037,995...170,085,392
|
|
G |
GPR87 |
G protein-coupled receptor 87 |
increases expression |
EXP |
methyleugenol results in increased expression of GPR87 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:151,294,086...151,316,820
Ensembl chr 3:151,294,086...151,316,820
|
|
G |
GPRC5A |
G protein-coupled receptor class C group 5 member A |
increases expression |
EXP |
methyleugenol results in increased expression of GPRC5A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:12,891,562...12,917,937
Ensembl chr12:12,890,782...12,917,937
|
|
G |
GPRC5B |
G protein-coupled receptor class C group 5 member B |
increases expression |
EXP |
methyleugenol results in increased expression of GPRC5B mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:19,856,691...19,885,634
Ensembl chr16:19,856,691...19,886,167
|
|
G |
GPRIN1 |
G protein regulated inducer of neurite outgrowth 1 |
increases expression |
EXP |
methyleugenol results in increased expression of GPRIN1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:176,595,802...176,610,156
Ensembl chr 5:176,595,802...176,610,156
|
|
G |
GPSM1 |
G protein signaling modulator 1 |
increases expression |
EXP |
methyleugenol results in increased expression of GPSM1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:136,327,539...136,359,601
Ensembl chr 9:136,327,476...136,359,605
|
|
G |
GPT |
glutamic--pyruvic transaminase |
decreases expression |
EXP |
methyleugenol results in decreased expression of GPT mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
GRAP |
GRB2 related adaptor protein |
decreases expression |
EXP |
methyleugenol results in decreased expression of GRAP mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:19,020,656...19,051,373
Ensembl chr17:19,020,656...19,047,011
|
|
G |
GREB1 |
growth regulating estrogen receptor binding 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GREB1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:11,482,888...11,642,788
Ensembl chr 2:11,482,341...11,642,788
|
|
G |
GRID1 |
glutamate ionotropic receptor delta type subunit 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GRID1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:85,599,552...86,366,795
Ensembl chr10:85,599,552...86,366,795
|
|
G |
GRID2 |
glutamate ionotropic receptor delta type subunit 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GRID2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:92,303,966...93,810,456
Ensembl chr 4:92,303,966...93,810,157
|
|
G |
GRIK4 |
glutamate ionotropic receptor kainate type subunit 4 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GRIK4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:120,511,748...120,988,906
Ensembl chr11:120,511,746...120,988,906
|
|
G |
GRIK5 |
glutamate ionotropic receptor kainate type subunit 5 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GRIK5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:41,998,324...42,070,206
Ensembl chr19:41,998,321...42,070,206
|
|
G |
GRIN2C |
glutamate ionotropic receptor NMDA type subunit 2C |
increases expression |
EXP |
methyleugenol results in increased expression of GRIN2C mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:74,842,023...74,861,532
Ensembl chr17:74,842,023...74,861,504
|
|
G |
GRIP1 |
glutamate receptor interacting protein 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GRIP1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:66,347,431...67,069,338
Ensembl chr12:66,347,431...67,069,162
|
|
G |
GRM3 |
glutamate metabotropic receptor 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GRM3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:86,643,909...86,864,879
Ensembl chr 7:86,643,909...86,864,879
|
|
G |
GRM8 |
glutamate metabotropic receptor 8 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GRM8 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:126,438,598...127,252,941
Ensembl chr 7:126,438,598...127,253,093
|
|
G |
GSTA1 |
glutathione S-transferase alpha 1 |
decreases activity |
EXP |
methyleugenol results in decreased activity of GSTA1 protein |
CTD |
PMID:8620581 |
|
NCBI chr 6:52,791,371...52,803,816
Ensembl chr 6:52,791,371...52,803,860
|
|
G |
GSTA2 |
glutathione S-transferase alpha 2 |
decreases activity |
ISO |
methyleugenol results in decreased activity of GSTA2 protein |
CTD |
PMID:8620581 |
|
NCBI chr 6:52,750,087...52,763,475
Ensembl chr 6:52,750,087...52,763,475
|
|
G |
GSTM1 |
glutathione S-transferase mu 1 |
decreases activity decreases expression |
EXP ISO |
methyleugenol results in decreased activity of GSTM1 protein methyleugenol results in decreased expression of GSTM1 mRNA |
CTD |
PMID:8620581 PMID:32234424 |
|
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
|
|
G |
GSTM2 |
glutathione S-transferase mu 2 |
decreases activity |
ISO |
methyleugenol results in decreased activity of GSTM2 protein |
CTD |
PMID:8620581 |
|
NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551
|
|
G |
GSTP1 |
glutathione S-transferase pi 1 |
decreases activity |
EXP ISO |
methyleugenol results in decreased activity of GSTP1 protein |
CTD |
PMID:8620581 |
|
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
|
|
G |
GTDC1 |
glycosyltransferase like domain containing 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GTDC1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:143,938,068...144,333,069
Ensembl chr 2:143,938,068...144,332,568
|
|
G |
GUCY1A2 |
guanylate cyclase 1 soluble subunit alpha 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GUCY1A2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:106,674,019...107,018,476
Ensembl chr11:106,674,019...107,018,476
|
|
G |
GUCY2D |
guanylate cyclase 2D, retinal |
decreases expression |
EXP |
methyleugenol results in decreased expression of GUCY2D mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:8,002,615...8,020,342
Ensembl chr17:8,002,615...8,020,342
|
|
G |
GULP1 |
GULP PTB domain containing engulfment adaptor 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GULP1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:188,291,874...188,595,926
Ensembl chr 2:188,291,669...188,595,931
|
|
G |
GYS2 |
glycogen synthase 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of GYS2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:21,532,577...21,604,847
Ensembl chr12:21,536,107...21,604,847
|
|
G |
H2AX |
H2A.X variant histone |
increases expression |
ISO |
methyleugenol results in increased expression of H2AX protein |
CTD |
PMID:26011634 |
|
NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,874...119,095,465
|
|
G |
H2BC3 |
H2B clustered histone 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of H2BC3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:26,043,227...26,043,713
Ensembl chr 6:26,042,771...26,043,713
|
|
G |
H2BC8 |
H2B clustered histone 8 |
decreases expression |
EXP |
methyleugenol results in decreased expression of H2BC8 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:26,216,200...26,216,688
Ensembl chr 6:26,216,200...26,216,688
|
|
G |
H3C1 |
H3 clustered histone 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of H3C1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:26,020,451...26,020,958
Ensembl chr 6:26,020,451...26,020,958
|
|
G |
HAGH |
hydroxyacylglutathione hydrolase |
decreases expression |
EXP |
methyleugenol results in decreased expression of HAGH mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:1,807,629...1,827,194
Ensembl chr16:1,795,620...1,827,157
|
|
G |
HAO2 |
hydroxyacid oxidase 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of HAO2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:119,368,785...119,394,130
Ensembl chr 1:119,368,779...119,394,130
|
|
G |
HAVCR2 |
hepatitis A virus cellular receptor 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of HAVCR2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:157,085,832...157,109,044
Ensembl chr 5:157,085,422...157,142,869
|
|
G |
HDAC4 |
histone deacetylase 4 |
decreases expression |
EXP |
methyleugenol results in decreased expression of HDAC4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:239,048,168...239,401,649
Ensembl chr 2:239,048,168...239,401,654
|
|
G |
HES2 |
hes family bHLH transcription factor 2 |
increases expression |
EXP |
methyleugenol results in increased expression of HES2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:6,415,232...6,419,919
Ensembl chr 1:6,412,418...6,424,670
|
|
G |
HHAT |
hedgehog acyltransferase |
decreases expression |
EXP |
methyleugenol results in decreased expression of HHAT mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:210,327,328...210,676,290
Ensembl chr 1:210,328,252...210,676,296
|
|
G |
HJV |
hemojuvelin BMP co-receptor |
decreases expression |
EXP |
methyleugenol results in decreased expression of HJV mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:146,017,470...146,021,735
Ensembl chr 1:146,017,468...146,036,746
|
|
G |
HLX-AS1 |
HLX antisense RNA 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of HLX-AS1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:220,832,763...220,880,140
Ensembl chr 1:220,832,763...220,881,473
|
|
G |
HMCN1 |
hemicentin 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of HMCN1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:185,734,391...186,190,949
Ensembl chr 1:185,734,391...186,190,949
|
|
G |
HMCN2 |
hemicentin 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of HMCN2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:130,265,760...130,434,123
Ensembl chr 9:130,265,760...130,434,123
|
|
G |
HMGA1 |
high mobility group AT-hook 1 |
increases expression |
EXP |
methyleugenol results in increased expression of HMGA1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:34,236,873...34,246,231
Ensembl chr 6:34,236,873...34,246,231
|
|
G |
HMGCS1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of HMGCS1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:43,287,470...43,313,412
Ensembl chr 5:43,287,470...43,313,512
|
|
G |
HMGCS2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of HMGCS2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:119,747,996...119,768,932
Ensembl chr 1:119,748,002...119,768,905
|
|
G |
HMMR |
hyaluronan mediated motility receptor |
decreases expression |
EXP |
methyleugenol results in decreased expression of HMMR mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:163,460,632...163,491,941
Ensembl chr 5:163,460,203...163,491,941
|
|
G |
HNF4A-AS1 |
HNF4A antisense RNA 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of HNF4A-AS1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr20:44,356,744...44,395,706
Ensembl chr20:44,359,756...44,395,706
|
|
G |
HNMT |
histamine N-methyltransferase |
decreases expression |
EXP |
methyleugenol results in decreased expression of HNMT mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:137,964,473...138,016,364
Ensembl chr 2:137,964,020...138,016,364
|
|
G |
HNRNPA1P33 |
heterogeneous nuclear ribonucleoprotein A1 pseudogene 33 |
decreases expression |
EXP |
methyleugenol results in decreased expression of HNRNPA1P33 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:46,415,853...46,416,416
Ensembl chr10:46,415,853...46,416,413
|
|
G |
HOGA1 |
4-hydroxy-2-oxoglutarate aldolase 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of HOGA1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:97,584,389...97,612,802
Ensembl chr10:97,584,323...97,612,802
|
|
G |
HOMER3 |
homer scaffold protein 3 |
increases expression |
EXP |
methyleugenol results in increased expression of HOMER3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:18,929,201...18,941,217
Ensembl chr19:18,929,201...18,941,261
|
|
G |
HORMAD2-AS1 |
HORMAD2 and MTMR3 antisense RNA 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of HORMAD2-AS1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr22:30,008,746...30,080,257
Ensembl chr22:30,008,740...30,080,480
|
|
G |
HOXB9 |
homeobox B9 |
increases expression |
EXP |
methyleugenol results in increased expression of HOXB9 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:48,621,156...48,626,358
Ensembl chr17:48,621,156...48,626,358
|
|
G |
HP |
haptoglobin |
decreases expression |
EXP |
methyleugenol results in decreased expression of HP mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:72,054,505...72,061,055
Ensembl chr16:72,054,505...72,061,055
|
|
G |
HPD |
4-hydroxyphenylpyruvate dioxygenase |
decreases expression |
EXP |
methyleugenol results in decreased expression of HPD mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:121,839,527...121,888,611
Ensembl chr12:121,839,527...121,863,596
|
|
G |
HPN |
hepsin |
decreases expression |
EXP |
methyleugenol results in decreased expression of HPN mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:35,040,506...35,066,573
Ensembl chr19:35,040,506...35,066,573
|
|
G |
HPR |
haptoglobin-related protein |
decreases expression |
EXP |
methyleugenol results in decreased expression of HPR mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:72,063,226...72,077,246
Ensembl chr16:72,063,148...72,077,246
|
|
G |
HPX |
hemopexin |
decreases expression |
EXP |
methyleugenol results in decreased expression of HPX mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:6,431,049...6,440,987
Ensembl chr11:6,431,049...6,442,617
|
|
G |
HRG |
histidine rich glycoprotein |
decreases expression |
EXP |
methyleugenol results in decreased expression of HRG mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:186,666,014...186,678,234
Ensembl chr 3:186,660,216...186,678,234
|
|
G |
HS6ST3 |
heparan sulfate 6-O-sulfotransferase 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of HS6ST3 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr13:96,090,107...96,839,562
Ensembl chr13:96,090,107...96,839,562
|
|
G |
HSD17B2 |
hydroxysteroid 17-beta dehydrogenase 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of HSD17B2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:82,035,253...82,098,534
Ensembl chr16:82,035,004...82,098,534
|
|
G |
HSD17B6 |
hydroxysteroid 17-beta dehydrogenase 6 |
decreases expression |
EXP |
methyleugenol results in decreased expression of HSD17B6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:56,763,324...56,787,790
Ensembl chr12:56,752,161...56,787,790
|
|
G |
HTR3A |
5-hydroxytryptamine receptor 3A |
increases expression |
EXP |
methyleugenol results in increased expression of HTR3A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:113,975,108...113,990,313
Ensembl chr11:113,975,075...113,990,313
|
|
G |
ICMT-DT |
ICMT divergent transcript |
decreases expression |
EXP |
methyleugenol results in decreased expression of ICMT-DT mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:6,236,240...6,239,444
Ensembl chr 1:6,234,692...6,239,448
|
|
G |
ID2 |
inhibitor of DNA binding 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ID2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461
|
|
G |
IDI1 |
isopentenyl-diphosphate delta isomerase 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of IDI1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:1,039,152...1,056,704
Ensembl chr10:1,039,152...1,049,119
|
|
G |
IDNK |
IDNK gluconokinase |
decreases expression |
EXP |
methyleugenol results in decreased expression of IDNK mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:83,623,006...83,644,123
Ensembl chr 9:83,623,049...83,644,130
|
|
G |
IER3 |
immediate early response 3 |
increases expression |
EXP |
methyleugenol results in increased expression of IER3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:30,743,199...30,744,547
Ensembl chr 6:30,743,199...30,744,548
|
|
G |
IGF1 |
insulin like growth factor 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of IGF1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
|
|
G |
IGSF23 |
immunoglobulin superfamily member 23 |
decreases expression |
EXP |
methyleugenol results in decreased expression of IGSF23 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:44,613,563...44,636,781
Ensembl chr19:44,613,563...44,636,781
|
|
G |
IGSF9 |
immunoglobulin superfamily member 9 |
decreases expression |
EXP |
methyleugenol results in decreased expression of IGSF9 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:159,927,041...159,945,613
Ensembl chr 1:159,927,039...159,945,613
|
|
G |
IL16 |
interleukin 16 |
decreases expression |
EXP |
methyleugenol results in decreased expression of IL16 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:81,182,712...81,314,058
Ensembl chr15:81,159,575...81,314,058
|
|
G |
IL1B |
interleukin 1 beta |
increases expression |
EXP |
methyleugenol results in increased expression of IL1B mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL1RL1 |
interleukin 1 receptor like 1 |
increases expression |
EXP |
methyleugenol results in increased expression of IL1RL1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:102,311,563...102,352,356
Ensembl chr 2:102,311,502...102,352,037
|
|
G |
IMMP2L |
inner mitochondrial membrane peptidase subunit 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of IMMP2L mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr 7:110,662,644...111,562,492
Ensembl chr 7:110,662,644...111,562,517
|
|
G |
IMPDH1 |
inosine monophosphate dehydrogenase 1 |
increases expression |
EXP |
methyleugenol results in increased expression of IMPDH1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:128,392,277...128,409,982
Ensembl chr 7:128,392,277...128,409,986
|
|
G |
IMPG2 |
interphotoreceptor matrix proteoglycan 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of IMPG2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:101,222,546...101,320,575
Ensembl chr 3:101,222,546...101,320,575
|
|
G |
INCENP |
inner centromere protein |
increases expression |
ISO |
methyleugenol results in increased expression of INCENP protein |
CTD |
PMID:23411599 |
|
NCBI chr11:62,124,011...62,153,169
Ensembl chr11:62,123,998...62,155,474
|
|
G |
INHBA |
inhibin subunit beta A |
decreases expression |
ISO EXP |
methyleugenol results in decreased expression of INHBA mRNA |
CTD |
PMID:15618236 PMID:32234424 |
|
NCBI chr 7:41,685,114...41,705,406
Ensembl chr 7:41,667,168...41,705,834
|
|
G |
INHBC |
inhibin subunit beta C |
decreases expression |
EXP |
methyleugenol results in decreased expression of INHBC mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:57,434,784...57,452,062
Ensembl chr12:57,434,784...57,452,062
|
|
G |
INHBE |
inhibin subunit beta E |
decreases expression |
EXP |
methyleugenol results in decreased expression of INHBE mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:57,455,307...57,458,025
Ensembl chr12:57,452,323...57,459,280
|
|
G |
INKA2 |
inka box actin regulator 2 |
increases expression |
EXP |
methyleugenol results in increased expression of INKA2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:111,722,064...111,755,797
Ensembl chr 1:111,680,630...111,755,824
|
|
G |
INPP4B |
inositol polyphosphate-4-phosphatase type II B |
decreases expression |
EXP |
methyleugenol results in decreased expression of INPP4B mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:142,023,160...142,846,535
Ensembl chr 4:142,023,160...142,847,432
|
|
G |
INSIG1 |
insulin induced gene 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of INSIG1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:155,297,878...155,310,235
Ensembl chr 7:155,297,776...155,310,235
|
|
G |
IQGAP2 |
IQ motif containing GTPase activating protein 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of IQGAP2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:76,403,285...76,708,132
Ensembl chr 5:76,403,285...76,708,132
|
|
G |
IQUB |
IQ motif and ubiquitin domain containing |
decreases expression |
EXP |
methyleugenol results in decreased expression of IQUB mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:123,452,193...123,534,595
Ensembl chr 7:123,452,193...123,535,077
|
|
G |
IRAG1 |
inositol 1,4,5-triphosphate receptor associated 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of IRAG1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:10,573,095...10,693,755
Ensembl chr11:10,573,091...10,693,988
|
|
G |
ITGA11 |
integrin subunit alpha 11 |
increases expression |
EXP |
methyleugenol results in increased expression of ITGA11 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:68,296,532...68,432,163
Ensembl chr15:68,296,532...68,432,163
|
|
G |
ITGA2 |
integrin subunit alpha 2 |
increases expression |
EXP |
methyleugenol results in increased expression of ITGA2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:52,989,352...53,094,779
Ensembl chr 5:52,989,340...53,094,779
|
|
G |
ITGA8 |
integrin subunit alpha 8 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ITGA8 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:15,513,954...15,719,922
Ensembl chr10:15,513,954...15,719,922
|
|
G |
ITGAX |
integrin subunit alpha X |
increases expression |
EXP |
methyleugenol results in increased expression of ITGAX mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:31,355,176...31,382,999
Ensembl chr16:31,355,134...31,382,999
|
|
G |
ITIH1 |
inter-alpha-trypsin inhibitor heavy chain 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ITIH1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:52,777,599...52,792,068
Ensembl chr 3:52,777,595...52,792,068
|
|
G |
ITPR1 |
inositol 1,4,5-trisphosphate receptor type 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ITPR1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:4,493,348...4,847,506
Ensembl chr 3:4,493,345...4,847,506
|
|
G |
ITPR3 |
inositol 1,4,5-trisphosphate receptor type 3 |
increases expression |
EXP |
methyleugenol results in increased expression of ITPR3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:33,621,322...33,696,562
Ensembl chr 6:33,620,365...33,696,574
|
|
G |
IYD |
iodotyrosine deiodinase |
decreases expression |
EXP |
methyleugenol results in decreased expression of IYD mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:150,369,012...150,405,969
Ensembl chr 6:150,368,892...150,405,969
|
|
G |
JAKMIP2 |
janus kinase and microtubule interacting protein 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of JAKMIP2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:147,585,438...147,782,728
Ensembl chr 5:147,585,438...147,782,775
|
|
G |
JPH2 |
junctophilin 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of JPH2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr20:44,106,590...44,187,188
Ensembl chr20:44,106,590...44,187,188
|
|
G |
JUNB |
JunB proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
methyleugenol results in increased expression of JUNB mRNA |
CTD |
PMID:15618236 |
|
NCBI chr19:12,791,486...12,793,315
Ensembl chr19:12,791,486...12,793,315
|
|
G |
KCND3 |
potassium voltage-gated channel subfamily D member 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of KCND3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:111,770,662...111,989,668
Ensembl chr 1:111,770,662...111,989,668
|
|
G |
KCNH5 |
potassium voltage-gated channel subfamily H member 5 |
decreases expression |
EXP |
methyleugenol results in decreased expression of KCNH5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:62,699,464...63,045,458
Ensembl chr14:62,699,464...63,102,037
|
|
G |
KCNH7 |
potassium voltage-gated channel subfamily H member 7 |
decreases expression |
EXP |
methyleugenol results in decreased expression of KCNH7 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:162,371,407...162,838,767
Ensembl chr 2:162,371,407...162,838,767
|
|
G |
KCNH8 |
potassium voltage-gated channel subfamily H member 8 |
decreases expression |
EXP |
methyleugenol results in decreased expression of KCNH8 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:19,148,510...19,535,642
Ensembl chr 3:19,148,510...19,535,642
|
|
G |
KCNJ3 |
potassium inwardly rectifying channel subfamily J member 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of KCNJ3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:154,698,695...154,858,354
Ensembl chr 2:154,697,855...154,858,354
|
|
G |
KCNK13 |
potassium two pore domain channel subfamily K member 13 |
decreases expression |
EXP |
methyleugenol results in decreased expression of KCNK13 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:90,061,994...90,185,853
Ensembl chr14:90,061,994...90,185,853
|
|
G |
KCNK5 |
potassium two pore domain channel subfamily K member 5 |
decreases expression |
EXP |
methyleugenol results in decreased expression of KCNK5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:39,188,971...39,229,475
Ensembl chr 6:39,188,971...39,229,475
|
|
G |
KCNMA1 |
potassium calcium-activated channel subfamily M alpha 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of KCNMA1 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr10:76,869,602...77,637,808
Ensembl chr10:76,869,601...77,638,369
|
|
G |
KCNQ5 |
potassium voltage-gated channel subfamily Q member 5 |
decreases expression |
EXP |
methyleugenol results in decreased expression of KCNQ5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:72,622,064...73,198,853
Ensembl chr 6:72,621,792...73,198,853
|
|
G |
KCNT2 |
potassium sodium-activated channel subfamily T member 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of KCNT2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:196,225,779...196,608,440
Ensembl chr 1:196,225,779...196,609,225
|
|
G |
KCNV1 |
potassium voltage-gated channel modifier subfamily V member 1 |
increases expression |
EXP |
methyleugenol results in increased expression of KCNV1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:109,963,636...109,975,771
Ensembl chr 8:109,963,636...109,975,771
|
|
G |
KCTD15 |
potassium channel tetramerization domain containing 15 |
increases expression |
EXP |
methyleugenol results in increased expression of KCTD15 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:33,794,040...33,815,761
Ensembl chr19:33,795,933...33,815,763
|
|
G |
KCTD16 |
potassium channel tetramerization domain containing 16 |
decreases expression |
EXP |
methyleugenol results in decreased expression of KCTD16 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:144,170,873...144,485,686
Ensembl chr 5:144,170,873...144,485,686
|
|
G |
KDM8 |
lysine demethylase 8 |
decreases expression |
EXP |
methyleugenol results in decreased expression of KDM8 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:27,203,526...27,221,768
Ensembl chr16:27,203,508...27,221,768
|
|
G |
KDR |
kinase insert domain receptor |
decreases expression |
EXP |
methyleugenol results in decreased expression of KDR mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595
|
|
G |
KHK |
ketohexokinase |
decreases expression |
EXP |
methyleugenol results in decreased expression of KHK mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:27,086,772...27,100,762
Ensembl chr 2:27,086,772...27,100,762
|
|
G |
KIAA0825 |
KIAA0825 |
decreases expression |
EXP |
methyleugenol results in decreased expression of KIAA0825 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:94,150,851...94,618,604
Ensembl chr 5:94,150,851...94,618,604
|
|
G |
KIAA1328 |
KIAA1328 |
decreases expression |
EXP |
methyleugenol results in decreased expression of KIAA1328 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr18:36,829,127...37,232,172
Ensembl chr18:36,829,106...37,232,172
|
|
G |
KIF17 |
kinesin family member 17 |
decreases expression |
EXP |
methyleugenol results in decreased expression of KIF17 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:20,661,630...20,718,007
Ensembl chr 1:20,664,014...20,718,017
|
|
G |
KIF20A |
kinesin family member 20A |
decreases expression |
EXP |
methyleugenol results in decreased expression of KIF20A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:138,179,112...138,187,723
Ensembl chr 5:138,178,719...138,187,723
|
|
G |
KIF26B |
kinesin family member 26B |
decreases expression |
EXP |
methyleugenol results in decreased expression of KIF26B mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:245,154,985...245,709,432
Ensembl chr 1:245,154,985...245,709,432
|
|
G |
KLB |
klotho beta |
decreases expression |
EXP |
methyleugenol results in decreased expression of KLB mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:39,406,930...39,451,533
Ensembl chr 4:39,406,930...39,451,533
|
|
G |
KLC4 |
kinesin light chain 4 |
decreases expression |
EXP |
methyleugenol results in decreased expression of KLC4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:43,059,631...43,075,093
Ensembl chr 6:43,040,777...43,075,095
|
|
G |
KLF12 |
KLF transcription factor 12 |
decreases expression |
EXP |
methyleugenol results in decreased expression of KLF12 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:73,686,089...74,306,045
Ensembl chr13:73,686,089...74,134,404
|
|
G |
KLF15 |
KLF transcription factor 15 |
decreases expression |
EXP |
methyleugenol results in decreased expression of KLF15 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:126,288,125...126,357,408
Ensembl chr 3:126,342,635...126,357,408
|
|
G |
KLF6 |
KLF transcription factor 6 |
increases expression |
ISO |
methyleugenol results in increased expression of KLF6 mRNA |
CTD |
PMID:23411599 |
|
NCBI chr10:3,775,996...3,785,209
Ensembl chr10:3,775,996...3,785,281
|
|
G |
KLHL32 |
kelch like family member 32 |
decreases expression |
EXP |
methyleugenol results in decreased expression of KLHL32 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:96,898,083...97,140,753
Ensembl chr 6:96,924,620...97,140,754
|
|
G |
KLKB1 |
kallikrein B1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of KLKB1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:186,210,853...186,258,471
Ensembl chr 4:186,226,438...186,258,471
|
|
G |
KMO |
kynurenine 3-monooxygenase |
decreases expression |
EXP |
methyleugenol results in decreased expression of KMO mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:241,532,378...241,595,642
Ensembl chr 1:241,532,134...241,595,642
|
|
G |
KNG1 |
kininogen 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of KNG1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:186,717,359...186,744,410
Ensembl chr 3:186,717,348...186,744,410
|
|
G |
KRT20 |
keratin 20 |
increases expression |
EXP |
methyleugenol results in increased expression of KRT20 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:40,875,889...40,885,242
Ensembl chr17:40,875,889...40,885,242
|
|
G |
KRT4 |
keratin 4 |
decreases expression |
EXP |
methyleugenol results in decreased expression of KRT4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:52,806,549...52,814,116
Ensembl chr12:52,806,549...52,814,116
|
|
G |
KRT5 |
keratin 5 |
decreases expression |
EXP |
methyleugenol results in decreased expression of KRT5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:52,514,575...52,520,394
Ensembl chr12:52,514,575...52,520,530
|
|
G |
KRT6A |
keratin 6A |
decreases expression |
EXP |
methyleugenol results in decreased expression of KRT6A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:52,487,176...52,493,257
Ensembl chr12:52,487,176...52,493,257
|
|
G |
LAIR1 |
leukocyte associated immunoglobulin like receptor 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LAIR1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:54,351,384...54,376,088
Ensembl chr19:54,351,384...54,370,558
|
|
G |
LARGE1 |
LARGE xylosyl- and glucuronyltransferase 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LARGE1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr22:33,066,663...33,922,824
Ensembl chr22:33,162,226...33,922,841
|
|
G |
LASP1 |
LIM and SH3 protein 1 |
increases expression |
EXP |
methyleugenol results in increased expression of LASP1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:38,870,058...38,921,770
Ensembl chr17:38,869,859...38,921,770
|
|
G |
LAT2 |
linker for activation of T cells family member 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LAT2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:74,210,006...74,229,834
Ensembl chr 7:74,199,652...74,229,834
|
|
G |
LBP |
lipopolysaccharide binding protein |
decreases expression |
EXP |
methyleugenol results in decreased expression of LBP mRNA |
CTD |
PMID:32234424 |
|
NCBI chr20:38,346,482...38,377,013
Ensembl chr20:38,346,482...38,377,013
|
|
G |
LCN12 |
lipocalin 12 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LCN12 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:136,949,197...136,956,538
Ensembl chr 9:136,949,551...136,955,497
|
|
G |
LDB2 |
LIM domain binding 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LDB2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:16,501,541...16,898,645
Ensembl chr 4:16,501,541...16,898,678
|
|
G |
LDLRAD4 |
low density lipoprotein receptor class A domain containing 4 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LDLRAD4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr18:13,217,682...13,652,754
Ensembl chr18:13,217,498...13,652,755
|
|
G |
LEAP2 |
liver enriched antimicrobial peptide 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LEAP2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:132,873,668...132,875,046
Ensembl chr 5:132,873,444...132,875,046
|
|
G |
LFNG |
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
increases expression |
EXP |
methyleugenol results in increased expression of LFNG mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:2,512,529...2,529,177
Ensembl chr 7:2,512,529...2,529,177
|
|
G |
LGALS4 |
galectin 4 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LGALS4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:38,801,674...38,812,945
Ensembl chr19:38,801,671...38,812,945
|
|
G |
LHPP |
phospholysine phosphohistidine inorganic pyrophosphate phosphatase |
decreases expression |
EXP |
methyleugenol results in decreased expression of LHPP mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:124,461,823...124,614,141
Ensembl chr10:124,461,823...124,617,888
|
|
G |
LIF |
LIF interleukin 6 family cytokine |
increases expression |
EXP |
methyleugenol results in increased expression of LIF mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr22:30,240,453...30,246,759
Ensembl chr22:30,240,453...30,246,759
|
|
G |
LINC00261 |
long intergenic non-protein coding RNA 261 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LINC00261 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr20:22,560,553...22,578,642
Ensembl chr20:22,547,663...22,578,642
|
|
G |
LINC00460 |
long intergenic non-protein coding RNA 460 |
increases expression |
EXP |
methyleugenol results in increased expression of LINC00460 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:106,376,564...106,378,595
Ensembl chr13:106,374,477...106,384,315
|
|
G |
LINC00574 |
long intergenic non-protein coding RNA 574 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LINC00574 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:169,790,073...169,802,873
Ensembl chr 6:169,790,036...169,890,808
|
|
G |
LINC00702 |
long intergenic non-protein coding RNA 702 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LINC00702 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:4,206,876...4,243,912
Ensembl chr10:4,201,141...4,268,709
|
|
G |
LINC00844 |
long intergenic non-protein coding RNA 844 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LINC00844 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:58,999,518...59,001,617
Ensembl chr10:58,967,778...59,066,396
|
|
G |
LINC00880 |
long intergenic non-protein coding RNA 880 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LINC00880 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:157,081,667...157,123,002
Ensembl chr 3:157,074,061...157,128,595
|
|
G |
LINC00887 |
long intergenic non-protein coding RNA 887 |
increases expression |
EXP |
methyleugenol results in increased expression of LINC00887 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:194,301,199...194,312,804
Ensembl chr 3:194,200,261...194,324,520
|
|
G |
LINC01085 |
long intergenic non-protein coding RNA 1085 |
increases expression |
EXP |
methyleugenol results in increased expression of LINC01085 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:14,111,968...14,140,052
Ensembl chr 4:14,126,339...14,126,664 Ensembl chr 4:14,126,339...14,126,664
|
|
G |
LINC01088 |
long intergenic non-protein coding RNA 1088 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LINC01088 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:78,971,748...79,308,799
Ensembl chr 4:78,938,871...79,309,673
|
|
G |
LINC01093 |
long intergenic non-protein coding RNA 1093 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LINC01093 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:184,893,000...184,899,461
Ensembl chr 4:184,892,858...184,899,908
|
|
G |
LINC01235 |
long intergenic non-protein coding RNA 1235 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LINC01235 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:13,406,380...13,431,329
Ensembl chr 9:13,406,323...13,488,125
|
|
G |
LINC01239 |
long intergenic non-protein coding RNA 1239 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LINC01239 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:22,646,200...22,824,213
Ensembl chr 9:22,640,681...22,824,213
|
|
G |
LINC01340 |
long intergenic non-protein coding RNA 1340 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LINC01340 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:97,504,696...97,671,051
Ensembl chr 5:97,504,589...97,989,061
|
|
G |
LINC01411 |
long intergenic non-protein coding RNA 1411 |
increases expression |
EXP |
methyleugenol results in increased expression of LINC01411 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:174,336,354...174,527,139
Ensembl chr 5:174,336,250...174,532,457
|
|
G |
LINC01524 |
long intergenic non-protein coding RNA 1524 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LINC01524 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr20:52,620,838...52,650,426
Ensembl chr20:52,192,159...52,699,472
|
|
G |
LINC01564 |
long intergenic non-protein coding RNA 1564 |
increases expression |
EXP |
methyleugenol results in increased expression of LINC01564 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:53,628,380...53,631,394
Ensembl chr 6:53,614,863...53,707,024
|
|
G |
LINC01572 |
long intergenic non-protein coding RNA 1572 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LINC01572 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:72,280,902...72,664,970
Ensembl chr16:72,236,281...72,665,083
|
|
G |
LINC01580 |
long intergenic non-protein coding RNA 1580 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LINC01580 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:93,900,701...93,984,150
Ensembl chr15:93,894,431...93,984,150
|
|
G |
LINC01787 |
long intergenic non-protein coding RNA 1787 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LINC01787 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:96,254,069...96,374,125
Ensembl chr 1:96,254,069...96,374,125
|
|
G |
LINC01954 |
long intergenic non-protein coding RNA 1954 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LINC01954 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:10,878,267...10,885,118
Ensembl chr 2:10,837,758...10,901,931
|
|
G |
LINC02027 |
long intergenic non-protein coding RNA 2027 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LINC02027 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:80,993,868...81,095,647
Ensembl chr 3:80,993,770...81,105,182
|
|
G |
LINC02166 |
long intergenic non-protein coding RNA 2166 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LINC02166 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:89,682,507...89,686,912
Ensembl chr16:89,682,506...89,686,921
|
|
G |
LINC02257 |
long intergenic non-protein coding RNA 2257 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LINC02257 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:221,913,645...221,978,520
Ensembl chr 1:221,811,869...222,064,817
|
|
G |
LINC02269 |
long intergenic non-protein coding RNA 2269 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LINC02269 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:173,897,273...173,929,525
Ensembl chr 4:173,699,082...174,001,488
|
|
G |
LINC02381 |
long intergenic non-protein coding RNA 2381 |
increases expression |
EXP |
methyleugenol results in increased expression of LINC02381 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:54,126,071...54,132,843
Ensembl chr12:54,126,019...54,147,485
|
|
G |
LINC02499 |
long intergenic non-protein coding RNA 2499 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LINC02499 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:73,508,803...73,528,533
Ensembl chr 4:73,508,232...73,534,128
|
|
G |
LINC02535 |
long intergenic non-protein coding RNA 2535 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LINC02535 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:85,387,219...85,404,802
Ensembl chr 6:85,320,314...85,404,911
|
|
G |
LINC02762 |
long intergenic non-protein coding RNA 2762 |
increases expression |
EXP |
methyleugenol results in increased expression of LINC02762 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:112,270,749...112,362,534
Ensembl chr11:112,270,707...112,376,036
|
|
G |
LINGO2 |
leucine rich repeat and Ig domain containing 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LINGO2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:27,937,617...29,213,601
Ensembl chr 9:27,937,617...29,213,601
|
|
G |
LINGO4 |
leucine rich repeat and Ig domain containing 4 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LINGO4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:151,800,264...151,805,419
Ensembl chr 1:151,800,264...151,805,419
|
|
G |
LIPC |
lipase C, hepatic type |
decreases expression |
EXP |
methyleugenol results in decreased expression of LIPC mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:58,431,991...58,569,844
Ensembl chr15:58,410,569...58,569,844
|
|
G |
LIPG |
lipase G, endothelial type |
decreases expression |
EXP |
methyleugenol results in decreased expression of LIPG mRNA |
CTD |
PMID:32234424 |
|
NCBI chr18:49,561,479...49,599,185
Ensembl chr18:49,560,699...49,599,185
|
|
G |
LMO2 |
LIM domain only 2 |
increases expression |
EXP |
methyleugenol results in increased expression of LMO2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:33,858,576...33,892,076
Ensembl chr11:33,858,576...33,892,076
|
|
G |
LNCOC1 |
lncRNA associated with ovarian cancer 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LNCOC1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:142,702,252...142,726,973
Ensembl chr 8:142,701,857...142,727,056
|
|
G |
LPCAT3 |
lysophosphatidylcholine acyltransferase 3 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LPCAT3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:6,976,185...7,018,476
Ensembl chr12:6,976,185...7,018,477
|
|
G |
LRBA |
LPS responsive beige-like anchor protein |
decreases expression |
EXP |
methyleugenol results in decreased expression of LRBA mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:150,264,435...151,015,727
Ensembl chr 4:150,264,435...151,015,727
|
|
G |
LRFN1 |
leucine rich repeat and fibronectin type III domain containing 1 |
increases expression |
EXP |
methyleugenol results in increased expression of LRFN1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:39,306,566...39,320,863
Ensembl chr19:39,306,566...39,320,863
|
|
G |
LRMDA |
leucine rich melanocyte differentiation associated |
decreases expression |
EXP |
methyleugenol results in decreased expression of LRMDA mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr10:75,431,624...76,560,168
Ensembl chr10:75,431,624...76,560,168
|
|
G |
LRP1B |
LDL receptor related protein 1B |
decreases expression |
EXP |
methyleugenol results in decreased expression of LRP1B mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:140,231,423...142,131,016
Ensembl chr 2:140,231,423...142,131,016
|
|
G |
LRP2 |
LDL receptor related protein 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LRP2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:169,127,109...169,362,534
Ensembl chr 2:169,127,109...169,362,534
|
|
G |
LRP8 |
LDL receptor related protein 8 |
increases expression |
EXP |
methyleugenol results in increased expression of LRP8 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:53,242,364...53,328,070
Ensembl chr 1:53,242,364...53,328,469
|
|
G |
LRRC37A11P |
leucine rich repeat containing 37 member A11, pseudogene |
decreases expression |
EXP |
methyleugenol results in decreased expression of LRRC37A11P mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:39,029,906...39,053,205
Ensembl chr17:39,027,277...39,045,347 Ensembl chr17:39,027,277...39,045,347
|
|
G |
LTBP1 |
latent transforming growth factor beta binding protein 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of LTBP1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:32,946,953...33,399,509
Ensembl chr 2:32,946,953...33,399,509
|
|
G |
LUCAT1 |
lung cancer associated transcript 1 |
increases expression |
EXP |
methyleugenol results in increased expression of LUCAT1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:91,302,986...91,314,402
Ensembl chr 5:91,054,834...91,314,547
|
|
G |
LY96 |
lymphocyte antigen 96 |
increases expression |
EXP |
methyleugenol results in increased expression of LY96 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:73,991,392...74,099,857
Ensembl chr 8:73,991,392...74,029,079
|
|
G |
LYPD1 |
LY6/PLAUR domain containing 1 |
increases expression |
EXP |
methyleugenol results in increased expression of LYPD1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:132,643,286...132,671,526
Ensembl chr 2:132,643,286...132,671,579
|
|
G |
MAB21L4 |
mab-21 like 4 |
decreases expression |
EXP |
methyleugenol results in decreased expression of MAB21L4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:240,886,048...240,896,839
Ensembl chr 2:240,886,048...240,896,889
|
|
G |
MACROD2 |
mono-ADP ribosylhydrolase 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of MACROD2 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr20:13,995,516...16,053,197
Ensembl chr20:13,995,369...16,053,197
|
|
G |
MAD1L1 |
mitotic arrest deficient 1 like 1 |
decreases expression |
ISO EXP |
methyleugenol results in decreased expression of MAD1L1 mRNA |
CTD |
PMID:26011634 PMID:32234424 |
|
NCBI chr 7:1,815,795...2,232,945
Ensembl chr 7:1,815,793...2,233,243
|
|
G |
MAD2L1 |
mitotic arrest deficient 2 like 1 |
affects expression |
ISO |
methyleugenol affects the expression of MAD2L1 mRNA |
CTD |
PMID:26011634 |
|
NCBI chr 4:120,055,623...120,066,848
Ensembl chr 4:120,055,623...120,066,858
|
|
G |
MAGI1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of MAGI1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:65,353,526...66,038,918
Ensembl chr 3:65,353,525...66,038,918
|
|
G |
MALRD1 |
MAM and LDL receptor class A domain containing 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of MALRD1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:19,046,927...19,734,478
Ensembl chr10:19,048,801...19,790,401
|
|
G |
MAN1C1 |
mannosidase alpha class 1C member 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of MAN1C1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:25,616,791...25,784,450
Ensembl chr 1:25,616,791...25,784,450
|
|
G |
MAP3K7CL |
MAP3K7 C-terminal like |
decreases expression |
EXP |
methyleugenol results in decreased expression of MAP3K7CL mRNA |
CTD |
PMID:32234424 |
|
NCBI chr21:29,077,114...29,175,887
Ensembl chr21:29,077,221...29,175,889
|
|
G |
MARCHF1 |
membrane associated ring-CH-type finger 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of MARCHF1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:163,524,298...164,384,019
Ensembl chr 4:163,524,298...164,384,050
|
|
G |
MARCKS |
myristoylated alanine rich protein kinase C substrate |
increases expression |
EXP |
methyleugenol results in increased expression of MARCKS mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:113,857,345...113,863,475
Ensembl chr 6:113,857,345...113,863,475
|
|
G |
MARCKSL1 |
MARCKS like 1 |
increases expression |
EXP |
methyleugenol results in increased expression of MARCKSL1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:32,333,839...32,336,233
Ensembl chr 1:32,333,839...32,336,233
|
|
G |
MAST4-AS1 |
MAST4 antisense RNA 1 |
increases expression |
EXP |
methyleugenol results in increased expression of MAST4-AS1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:67,001,618...67,004,154
Ensembl chr 5:66,988,877...67,004,250
|
|
G |
MAT1A |
methionine adenosyltransferase 1A |
decreases expression |
EXP |
methyleugenol results in decreased expression of MAT1A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:80,271,820...80,289,658
Ensembl chr10:80,271,820...80,289,658
|
|
G |
MATN2 |
matrilin 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of MATN2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:97,869,064...98,036,724
Ensembl chr 8:97,868,840...98,036,724
|
|
G |
MB |
myoglobin |
decreases expression |
EXP |
methyleugenol results in decreased expression of MB mRNA |
CTD |
PMID:32234424 |
|
NCBI chr22:35,606,764...35,623,354
Ensembl chr22:35,606,764...35,637,951
|
|
G |
MB21D2 |
Mab-21 domain containing 2 |
increases expression |
EXP |
methyleugenol results in increased expression of MB21D2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:192,796,815...192,917,856
Ensembl chr 3:192,796,815...192,917,856
|
|
G |
MBL2 |
mannose binding lectin 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of MBL2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
|
|
G |
MCF2 |
MCF.2 cell line derived transforming sequence |
decreases expression |
EXP |
methyleugenol results in decreased expression of MCF2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr X:139,581,770...139,708,167
Ensembl chr X:139,581,770...139,708,216
|
|
G |
MCHR1 |
melanin concentrating hormone receptor 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of MCHR1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr22:40,679,484...40,682,812
Ensembl chr22:40,679,273...40,682,812
|
|
G |
MCTP1 |
multiple C2 and transmembrane domain containing 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of MCTP1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:94,703,690...95,285,094
Ensembl chr 5:94,703,690...95,285,094
|
|
G |
MDGA2 |
MAM domain containing glycosylphosphatidylinositol anchor 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of MDGA2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:46,839,623...47,675,605
Ensembl chr14:46,840,092...47,675,605
|
|
G |
MDK |
midkine |
increases expression |
EXP |
methyleugenol results in increased expression of MDK mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:46,380,784...46,383,837
Ensembl chr11:46,380,756...46,383,837
|
|
G |
MDM2 |
MDM2 proto-oncogene |
increases expression |
ISO |
methyleugenol results in increased expression of MDM2 mRNA |
CTD |
PMID:26011634 |
|
NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544
|
|
G |
MELTF |
melanotransferrin |
increases expression |
EXP |
methyleugenol results in increased expression of MELTF mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:197,001,740...197,029,817
Ensembl chr 3:196,980,590...197,029,835
|
|
G |
MEP1B |
meprin A subunit beta |
decreases expression |
EXP |
methyleugenol results in decreased expression of MEP1B mRNA |
CTD |
PMID:32234424 |
|
NCBI chr18:32,190,039...32,220,404
Ensembl chr18:32,185,069...32,220,404
|
|
G |
MFSD2A |
MFSD2 lysolipid transporter A, lysophospholipid |
decreases expression |
EXP |
methyleugenol results in decreased expression of MFSD2A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:39,955,145...39,969,956
Ensembl chr 1:39,955,112...39,969,968
|
|
G |
MGMT |
O-6-methylguanine-DNA methyltransferase |
decreases expression |
EXP |
methyleugenol results in decreased expression of MGMT mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:129,467,241...129,770,983
Ensembl chr10:129,467,190...129,770,983
|
|
G |
MILR1 |
mast cell immunoglobulin like receptor 1 |
increases expression |
EXP |
methyleugenol results in increased expression of MILR1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:64,449,115...64,497,356
Ensembl chr17:64,449,037...64,492,770
|
|
G |
MIR3189 |
microRNA 3189 |
increases expression |
EXP |
methyleugenol results in increased expression of MIR3189 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:18,386,562...18,386,634
Ensembl chr19:18,386,562...18,386,634
|
|
G |
MKI67 |
marker of proliferation Ki-67 |
increases expression |
ISO |
methyleugenol results in increased expression of MKI67 protein |
CTD |
PMID:23411599 PMID:26011634 |
|
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
|
|
G |
MLIP |
muscular LMNA interacting protein |
decreases expression |
EXP |
methyleugenol results in decreased expression of MLIP mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:54,018,970...54,266,280
Ensembl chr 6:53,929,982...54,266,280
|
|
G |
MLKL |
mixed lineage kinase domain like pseudokinase |
increases expression |
EXP |
methyleugenol results in increased expression of MLKL mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:74,671,855...74,700,862
Ensembl chr16:74,671,855...74,700,960
|
|
G |
MLPH |
melanophilin |
increases expression |
EXP |
methyleugenol results in increased expression of MLPH mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:237,486,410...237,555,322
Ensembl chr 2:237,485,428...237,555,322
|
|
G |
MMADHC-DT |
MMADHC divergent transcript |
decreases expression |
EXP |
methyleugenol results in decreased expression of MMADHC-DT mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:149,587,358...149,848,234
Ensembl chr 2:149,587,196...150,047,447
|
|
G |
MMP10 |
matrix metallopeptidase 10 |
increases expression |
EXP |
methyleugenol results in increased expression of MMP10 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:102,770,502...102,780,628
Ensembl chr11:102,770,502...102,780,628
|
|
G |
MMP12 |
matrix metallopeptidase 12 |
increases expression |
EXP |
methyleugenol results in increased expression of MMP12 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:102,862,736...102,874,982
Ensembl chr11:102,862,736...102,874,982
|
|
G |
MMUT |
methylmalonyl-CoA mutase |
decreases expression |
EXP |
methyleugenol results in decreased expression of MMUT mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:49,430,360...49,463,253
Ensembl chr 6:49,430,360...49,463,253
|
|
G |
MOGAT2 |
monoacylglycerol O-acyltransferase 2 |
decreases expression |
EXP | |